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Postoperative atrial ﬁbrillation (AF) is the most common arrhythmia following cardiac
surgery with extracorporeal circulation.The pathogenesis of postoperative AF is multifac-
torial. Oxidative stress, caused by the unavoidable ischemia–reperfusion event occurring in
this setting, is a major contributory factor. Reactive oxygen species (ROS)-derived effects
could result in lipid peroxidation, protein carbonylation, or DNA oxidation of cardiac tis-
sue, thus leading to functional and structural myocardial remodeling. The vulnerability of
myocardial tissue to the oxidative challenge is also dependent on the activity of the antiox-
idant system. High ROS levels, overwhelming this system, should result in deleterious
cellular effects, such as the induction of necrosis, apoptosis, or autophagy. Nevertheless,
tissue exposure to low to moderate ROS levels could trigger a survival response with a
trend to reinforce the antioxidant defense system. Administration of n−3 polyunsaturated
fatty acids (PUFA), known to involve a moderate ROS production, is consistent with a
diminished vulnerability to the development of postoperative AF . Accordingly, supplemen-
tation of n−3 PUFA successfully reduced the incidence of postoperative AF after coronary
bypass grafting.This response is due to an up-regulation of antioxidant enzymes, as shown
in experimental models. In turn, non-enzymatic antioxidant reinforcement through vitamin
C administration prior to cardiac surgery has also reduced the postoperative AF incidence.
Therefore, it should be expected that a mixed therapy result in an improvement of the
cardioprotective effect by modulating both components of the antioxidant system. We
present novel available evidence supporting the hypothesis of an effective prevention of
postoperative AF including a two-step therapeutic strategy: n−3 PUFA followed by vitamin
C supplementation to patients scheduled for cardiac surgery with extracorporeal circula-
tion. The present study should encourage the design of clinical trials aimed to test the
efﬁcacy of this strategy to offer new therapeutic opportunities to patients challenged by
ischemia–reperfusion events not solely in heart, but also in other organs such as kidney or
liver in transplantation surgeries.
Keywords: postoperative atrial ﬁbrillation, oxidative stress, vitamin C, vitamin E, n−3 polyunsaturated fatty acids
INTRODUCTION
Atrial ﬁbrillation (AF) is the most common arrhythmia affect-
ing patients after general thoracic surgery. It is associated with
increasedriskof strokeanddeathandconstitutesasubstantialuse
of healthcare resources, including increased duration of hospital-
ization and hospital costs (Zimmer et al., 2003; Gillespie et al.,
2005, 2006). Together with ﬂutter, it is one of the two most the
commonarrhythmiasthatdevelopinpatientspostoperativelyfol-
lowing coronary artery bypass graft surgery with extracorporeal
circulation. Age is the only risk factor most consistently identi-
ﬁed as a major independent predictor for the development of
postoperative AF. Among other risk factors even a genetic pre-
disposition is plausible since there is inﬂuence of race (Rader
et al., 2011). Despite the available resources of all the modern
antiarrhythmic drugs for effective prophylaxis and advances in
surgical techniques, the incidence of postoperative AF remains
unchanged, ranging from 15 to 40% (Maisel et al., 2001; Elahi
et al., 2003; Mathew et al., 2004). Postoperative AF is associated
with signiﬁcant morbidity and mortality (Villareal et al.,2004; El-
Chami et al., 2010). Moreover, it has been recognized as a risk
factor for short-term morbidity and decreased long-term survival
(Saxena et al., 2012). It was reported that intensive care unit stay
and hospital stay as well as in-hospital mortality were also signiﬁ-
cantlyhigheramongthepatientswithAFcomparedwiththesinus
rhythm group (Attaran et al., 2011). The precise pathophysiology
of postoperative AF is unknown, however most of the evidence
suggests it is multifactorial (Alqahtani, 2010). The problem of AF
is now widely appreciated, but the underlying mechanisms that
lead to onset and persistence of arrhythmia have been difﬁcult
to elucidate (Van Wagoner, 2007). It is of interest that despite
the documented clinical impact of postoperative AF, the lack of
mechanistic understanding of its occurrence has contributed in
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part to explain why there are no uniformly accepted treatments
for its prevention. The pathophysiological mechanisms of post-
operative AF are inﬂuenced by preoperative, intraoperative, and
postoperative factors. In on-pump cardiac surgery, the unavoid-
able occurrence of an ischemia–reperfusion event leads to the
formation of reactive oxygen species (ROS), causing oxidative
stress, and a systemic inﬂammatory response (Matata et al., 2000;
Elahi et al., 2008; Van Wagoner, 2008). ROS react with cell mol-
ecules such as lipids, proteins, and nucleic acids, leading to alter-
ations of a variety of metabolic pathways and abnormal function
of cellular structures and macromolecules. Thus, ROS-mediated
oxidative damage of cardiomyocyte is characterized by processes
suchaslipidperoxidation,proteincarbonylationand/ornitration,
DNA oxidation, among others, accounting for structural modiﬁ-
cations in cardiac tissue. Accumulating evidence suggests a link
between AF and myocardial oxidative processes, since the latter
may contribute to atrial remodeling (Korantzopoulos et al., 2003;
Van Wagoner, 2003). These changes are associated with break-
down of cell membrane, impairment of mitochondrial function,
calcium overload, and apoptosis. In turn, there has been emerg-
ing data to support the association between inﬂammation and
AF (Boos et al., 2006). Oxidative stress triggers proinﬂammatory
signaling pathways that activate nuclear factor kappaB (NF-κB)
and AP-1 transcription factors (Bowie and O’Neill, 2000). The
deleterious consequences of high ROS exposure, such as inﬂam-
mation,celldeath(apoptosis/autophagy/necrosis),orﬁbrosis,may
be abrogated by myocardial preconditioning caused by previ-
ous exposure to moderate ROS concentration known to trigger
survival response mechanisms (Fruehauf and Meyskens, 2007).
Marked inﬂammatory inﬁltrates, myocyte necrosis, and ﬁbrosis
have been demonstrated in the atrial biopsies of patients with
lone AF refractory to antiarrhythmic drug therapy, but not in
control patients (Frustaci et al., 1997). Consequently, the struc-
tural cardiomyocyte alterations may give rise to aberrations in
impulse generation, propagation, or the duration and conﬁgura-
tion of individual cardiac action potentials, thus accounting for
the basis of disorders of cardiac rhythm. The Na+ channel plays
a central role in the generation of sinus rhythm and its alteration
is associated with AF (Grant, 2001; Olson et al., 2005). Therefore,
the myocardial oxidative injury can lead to increased susceptibil-
ity to postoperative AF. On the basis of this paradigm, it should
be expected that a reinforcement of the antioxidant defense sys-
tem, prior to the oxidative challenge, results in a cardioprotective
effect expressed by a decreased incidence of postoperative AF. Up
to date,to our knowledge,the largely empirical prophylactic ther-
apies have not taken into account this point of view. This study
presentsthemolecularbasistoachieveadecreasedvulnerabilityof
myocardialtissuetotheoxidativechallengecreatedbyitsexposure
totheischemia–reperfusionoccurringduringcardiacsurgerywith
extracorporeal circulation (on-pump). The novel pharmacologi-
cal design is based on a two-step strategy aimed to exert a positive
modulation of the antioxidant system.
IMPLICATIONS OF OXIDATIVE STRESS FOR HEART DISEASE
GENERAL ASPECTS OF OXIDATIVE STRESS
Oxidative stress constitutes a unifying mechanism of injury of
many types of disease processes (Rodrigo, 2009), it occurs when
there is an imbalance between the generation of ROS and the
antioxidant defense systems in the body so that the latter become
overwhelmed (Juránek and Bezek, 2005). In the cellular metab-
olism, the oxygen molecule itself is reduced to water after form-
ing, as successive intermediates, superoxide, hydrogen peroxide
(H2O2), and hydroxyl radical. It is estimated that between 0.15
and 2% of cellular O2 consumption results in superoxide for-
mation (Tahara et al., 2009). In turn, RNS mainly include nitric
oxide (NO),peroxynitrite anion (ONOO−) that is the product of
the reaction between NO and superoxide, and nitrogen dioxide
radical (NOO·) formed during the homolytic decomposition of
peroxynitrous acid. Ischemic heart disease is perhaps the human
condition in which the role of oxidative stress has been investi-
gated in more detail. There is major evidence on the contribution
of oxidativestresstomyocardialdamageinclinicalsettingsrelated
to ischemia–reperfusion events, such as acute myocardial infarc-
tion, percutaneous coronary interventions following myocardial
infarction or postoperative AF, among others. ROS and RNS and
consequent expression of oxidative damage have been demon-
strated both in ischemia and during post-ischemic reperfusion in
humans. However, they may also participate as important signal-
ing species in the normal physiology of healthy cells. Moreover,
available evidence suggests that these molecules can trigger defen-
sivemechanismsessentialforcellsurvival.Theroleofintermediate
metabolism during myocardial ischemia together with the cel-
lular redox state might represent a promising interpretative key
(Ceconi et al., 2003). The mitochondrial electron transport chain
isinvolvedinoxygensensingandwouldthereforeneedtorespond
to changes in oxygen levels (Debreceni and Debreceni, 2011).
ROS SOURCES
Cardiac myocytes are able to generate ROS in a variety of ways.
The greatest ROS source is from electrons lost during transfer
between electron transport chain complexes in mitochondrial
oxidativephosphorylationprocesses.MitochondrialROSarepro-
duced during oxidative metabolism through the one electron
r e d u c t i o no fo x y g e n( O 2) to form superoxide; the mitochondr-
ial electron transport chain generates superoxide predominantly
at complexes I and III (Murphy, 2009). In addition, ROS can be
generatedfromenzymes,suchasNADPHoxidase(fromheartand
phagocytes),uncoupled endothelial nitric oxide synthase (eNOS),
xanthine oxidase (XO), and lipoxygenase/cyclooxygenase, aside
from the oxidation of catecholamines. NADPH oxidase activity
occurs in cardiomyocytes and heart endothelial cells. Further-
more, the phagocytic NADPH oxidase NOX2 (gp91) produces
superoxide anions by reducing O2 (Brown and Griendling,2009);
local non-phagocytic NADPH oxidases have been implicated in
ROS production following growth factor and cytokine stimula-
tion (Ushio-Fukai, 2009). The cellular effects of ROS are partially
mediated by NF-κB activation. NF-κB mainly exists in the cytosol
as a pre-formed trimeric complex that consists of the inhibitory
protein IκB and the P50/P65 protein dimer. ROS induce redox
changes that result in phosphorylation of IκB subunit, thereby
activating its proteolytic digestion. When the inhibitor subunit is
dislodged from the P60/P65 heterodimer, NF-κB can translocate
to the nucleus, bind DNA, and initiate transcription. In addi-
tion to being a major mediator of cytokine effects in the heart,
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NF-κB regulates cardiac gene expression programs downstream
of multiple signal transduction cascades in a variety of physi-
ological and pathophysiological states. Blocking NF-κB reduces
infarct size in the murine heart after ischemia–reperfusion (Jones
et al., 2003), implicating NF-κB as a major determinant of cell
death in this setting, thus supporting the concept that it may be
animportanttherapeutictargetforspeciﬁccardiovasculardisease.
Antioxidants,includingvitaminE,canabrogateNF-κBactivation.
Oxidation of P50 on its DNA-binding domain has been shown
to act as a protective mechanism by preventing NF-κB binding
(Wangetal.,2011a).Finally,anovelzinc-ﬁngerprotein,monocyte
chemoattractantprotein-1(MCP-1)-inducedprotein(MCPIP),is
thought to have NF-κB inhibitory activity in certain cell cultures,
butitspathophysiologicalconsequenceinvivo remainsundeﬁned.
Compared with lipopolysaccharide (LPS)-treated wild-type mice,
MCPIP transgenic mice have markedly reduced levels of myocar-
dial inﬂammatory cytokines, less iNOS expression and peroxyni-
triteformation,decreasedcaspase-3/7activities,andapoptoticcell
death. This novel protein might protect the heart from inﬂamma-
tory pathologies, possibly through inhibition of the IκB kinase
complex, which prevents NF-κB activation, and attenuates the
proinﬂammatory state and nitrosative stress in the myocardium
(Niu et al., 2011).
ANTIOXIDANT DEFENSES
Enzymatic antioxidant defenses include superoxide dismutase
(SOD), glutathione peroxidase (GSH-Px), and catalase (CAT).
Non-enzymatic antioxidants include a variety of mostly exoge-
nous biological molecules, such as ascorbic acid (vitamin C), α-
tocopherol (vitamin E), reduced glutathione (GSH), carotenoids,
ﬂavonoids, polyphenols, and other exogenous antioxidants (Gas-
paretto et al.,2005). Oxidative stress develops when ROS produc-
tion is sufﬁcient to overwhelm the antioxidant defense system,
which leads to increased ROS and RNS steady-state concentra-
tions thereby damaging biomolecules. Examples of pathophys-
iological cardiac states associated with oxidative stress derived
from ischemia and reperfusion are acute myocardial infarction,
cardiac surgery with extracorporeal circulation and heart trans-
plantation, among others. The vulnerability of myocardial tis-
sue to oxidative challenges caused by reperfusion is dependent
on antioxidant system activity. The ﬁrst line of cellular defense
against oxidative injury include the antioxidant enzymes CAT,
SOD, and GSH-Px. MnSOD overexpression protects the murine
myocardiumfrompost-ischemicinjury;however,neitherGSH-Px
norCu/ZnSODappeartobeimportantdeterminantsof theextent
of myocardial injury in this in vivo model (Jones et al., 2003).
Consistent with this view, it has been reported that infarct size is
markedlyreducedintransgenicmicethatover-expressSOD(Chen
et al.,1998). In contrast,in a tamoxifen-inducible cardiomyocyte-
speciﬁc catalase-over-expressing mouse model, there were no
acute functional improvements with physiological CAT overex-
pression before myocardial infarction. However, hydrogen perox-
ide scavenging reduced proinﬂammatory cytokines and altered
cardiaccollagenisoforms,associatedwithanimprovementincar-
diacfunctionafter21days.Thesedatasuggestthatsustainedrather
thanacuteH2O2 levelsmayberelevantinthemyocardialremodel-
ingandcardiacfunction(Pendergrassetal.,2011).Mitochondrial
and cell cytosolic components of the antioxidant system can
neutralize excess mitochondrial ROS under most conditions.
Reactive oxygen species are not just by-products of mitochon-
drial respiration, but also play a key role in cell signaling. Cardiac
tissue exposure to low to moderate ROS levels should trigger a
survival response and reinforce ROS scavengers of the antioxidant
defense system to elicit a cardioprotective effect for myocardial
reperfusion.Infact,themolecularmechanismresponsibleforthis
adaptive change involves enhanced antioxidant activity achieved
byup-regulatingseveralhousekeepinggenespartlyunderthecon-
trol of nuclear factor erythroid 2-related factor-2 (Nrf2). Nrf2 is
normally sequestered in the cytosol by Kelch-like ECH-associated
protein 1 (Keap1). Upon oxidative stimulation, Nrf2 oxidizes or
covalently modiﬁes Keap1 thiol groups, dissociates from Keap1
and undergoes nuclear translocation. In the nucleus, Nrf2 binds
to antioxidant response elements (ARE) in target gene promoters
(Kobayashi and Yamamoto, 2005), which increase the expression
of antioxidant enzymes. It was demonstrated that the constitu-
tive levels/activities of a number of important antioxidants and
phase 2 enzymes, such as CAT, GSH-Px, glutathione reductase,
glutathione S-transferase, NAD(P)H:quinone oxidoreductase 1,
and heme oxygenase-1 in primary cardiomyocytes are dependent
on Nrf2 status. Therefore, Nrf2 should be expected to contribute
to diminish the susceptibility of cardiomyocytes to injury elicited
byoxidantsandelectrophilicspecies(Zhuetal.,2008),makingthe
Nrf2 signaling pathway an important mechanism for myocardial
cytoprotection.
It is of interest to note that the magnitude of ROS levels could
determine the activation of NF-κB and/or Nrf2 pathways.
PATHOPHYSIOLOGY OF ROS-MEDIATED POSTOPERATIVE ATRIAL
FIBRILLATION
Thepathophysiologicaleffectsof ROSdependuponthetype,con-
centration,andspeciﬁcsiteof productionandinvolvethreebroad
types of action. A wide mechanistic survey of AF is beyond the
scopeof thepresentreview,butithasbeenpreviouslydiscussedin
detail (Van Wagoner,2007). This section is devoted to present the
experimental and clinical evidence to account for the role of ROS
in the pathogenesis of AF following cardiac surgery.
Multiple lines of evidence have strongly suggested a link
between oxidative stress and cardiac arrhythmias, especially AF
(Neuman et al., 2007; Negi et al., 2010). Interestingly, cardiac
surgery has also been reported to increase oxidative stress as
measured by thiol ratios in the plasma and myocardium (De
Vecchi et al., 1998). Moreover, these data suggest that oxidative
stress markers may have predictive value in AF management.
Interestingly, recent studies have demonstrated the implication
of oxidative stress within the atrial tissue during AF suggesting
a potential role in the remodeling phenomenon (Van Wagoner,
2003; Korantzopoulos et al.,2007).
Further evidence of the role of ROS and RNS in the develop-
ment of AF has been provided. Thus, AF induced by rapid atrial
pacing in pigs is characterized by increased nicotinamide adenine
dinucleotide phosphate (NADPH) oxidase activity and superox-
ide production in the left atrium (Dudley et al., 2005). Right
human atrial appendages of patients with AF exhibit higher lev-
els of the nitrosative and oxidative stress markers 3-nitrotyrosine
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and protein carbonyls, respectively, compared with patients with
sinus rhythm (Mihm et al., 2001). In mice, chronic cardiac over-
expression of Rac1 represents a novel model for AF. Rac1 GTPase
contributestothepathogenesisof AFandmightrepresentatarget
for the prevention and its treatment (Adam et al.,2007).
Myocardial ischemia–reperfusion
Themyocardiumcantoleratebriefperiods(upto15min)ofsevere
and even total myocardial ischemia without resultant cardiomy-
ocyte death. This is observed in clinical settings like coronary
vasospasm, angina, and balloon angioplasty, and is therefore not
associated with concomitant myocyte death (Kloner and Jen-
nings, 2001a,b). It was suggested that endothelial dysfunction
occurs early during reperfusion of a previously ischemic tissue
and that it will be present for long time (Lefer and Lefer, 1996).
Thehypoxiaandreoxygenationsigniﬁcantlyincreasedpulmonary
veinsarrhythmogenesisandinducesdifferentelectrophysiological
responses in the right and left atria, which may play a role in the
pathophysiologyofAF(Linetal.,2012).Inaclinicalsetting,reper-
fusion injury after revascularization of the ischemia-related artery
is manifested by myocardial stunning, reperfusion arrhythmia,
myocyte death, and endothelial- and microvascular-dysfunction
including the no-reﬂow phenomenon (Moens et al., 2005). Early
reperfusion is an absolute prerequisite for the survival of ischemic
myocardium.However,thisprocesshasbeenreferredasthedouble
edgedswordbecausereperfusionmayitself leadtoacceleratedand
additional myocardial injury beyond that generated by ischemia
alone (Braunwald and Kloner, 1985). This paradoxical effect
results in a spectrum of reperfusion-associated pathologies, col-
lectively called reperfusion injury (Yellon and Hausenloy, 2007).
Theseobservationsareconsistentwiththenotionthatreintroduc-
tionof abundantoxygenattheonsetof reperfusionevokesaburst
of ROS within the ﬁrst few minutes of reﬂow as demonstrated
experimentally and in patients with acute myocardial infarction
undergoing thrombolysis (Béard et al., 1994) or percutaneous
coronaryintervention(Babuetal.,2011),andpatientsundergoing
open heart on-pump surgery (Akila et al.,2007).
Role of oxidative stress in atrial ﬁbrillation
The ability of tissues to tolerate ROS is partly conditioned by
the activity of their antioxidant defense system to scavenge and
degrade ROS to non-toxic molecules. Antioxidant enzymes are
mainlylocatedintheintracellularspace,and,theantioxidantmol-
ecules both within the intra- and extra-cellular spaces. The setting
of an ischemia–reperfusion event alters this homeostasis giving
risetoaprevalenceofprooxidantsoverantioxidantactivity(oxida-
tive stress). Consequently,the increased ROS concentration at the
steady-state causes direct damage to lipids, proteins, and DNA.
A large body of experimental evidence supports the notion that
ROS-generated reperfusion injury occurs when oxygen is reintro-
duced to the ischemic tissue (Hess and Manson, 1984; Weisfeldt
et al.,1988;Opie,1991;Kilgore and Lucchesi,1993;Zughaib et al.,
1994;Ambrosio and Tritto,1999;Park and Lucchesi,1999). Previ-
ously, it has been proposed the beneﬁcial effects of ROS occur at
moderate concentrations and involve physiological roles in cellu-
lar responses (Martindale and Holbrook,2002;Valko et al.,2007).
It is of interest to mention that superoxide is able to react with
nitricoxide(NO)viaahighrateconstantnon-enzymaticreaction
to form peroxynitrite, a highly peroxidant molecule responsible
foradditionalstructuralchanges,suchasnitrotyrosinederivatives
formation, nitrosylation, and oxidation of thiol groups. Redox
signaling processes are involved in the activation of many signal
transduction protein kinases and transcription factors,the stimu-
lation of DNA synthesis and expression of growth-related genes,
andtheregulationof myocardialexcitation–contractioncoupling.
Interestingly, while high levels of peroxynitrite may induce non-
speciﬁc toxic effects, at lower levels it is capable of modulating
signaling events in vivo indicating an additional level of complex-
ity. NO synthase normally generate NO but may instead generate
superoxide if it becomes“uncoupled,”a state that may occur from
deﬁciencyof NOScofactortetrahydrobiopterin(BH4)ortheNOS
substrate l-arginine (Verhaar et al.,2004). Interestingly,ROS pro-
duced by NADPH oxidases can promote ROS generation by other
sources thereby amplifying total levels of ROS. Superoxide may
oxidize and degrade BH4, thereby leading to eNOS uncoupling.
Similarly, NADPH oxidase-derived ROS may also activate xan-
thine oxidase (Li and Shah, 2004). The evidence indicates that
the primary source of superoxide production in the human atrial
myocardium is an NADPH oxidase, whose activity is increased in
AFpatientscomparedwithmatchedpatientsinsinusrhythm(Kim
et al.,2005),what is accompanied by increased mRNA expression
of NOX2 and P22 phox. In addition, it was reported that AF is
associated with a 6.9-fold increase in active Rac1 (Adam et al.,
2007). Possible mechanisms of Rac1 activation include increased
AngIIreceptoractivation,orincreasedcytosolicCa2+ (Wassmann
et al.,2001; Cook-Mills et al.,2004; Li et al.,2006).
Atrial remodeling and ROS
Compelling evidence shows that AF development and perpetua-
tion depends on the electrophysiological and structural substrates
of the atria (Allessie et al., 2002; Nattel et al., 2007). The struc-
tural substrates refer to abnormalities in atrial architecture such
as atrial dilatation (Kojodjojo et al., 2007), ﬁbrosis (Everett and
Olgin, 2007), apoptosis phenomena, tissue dedifferentiation, etc.
(Shiroshita-Takeshita et al., 2005). The cardiomyocytes have to
copewithnewcircumstancesandconsequentlychangetheexpres-
sion and organization pattern of proteins involved in activation,
conduction, and contraction. Ions like Ca2+,N a +, and K+ are
important players in the excitation–contraction cycle, and the
expression patterns of their channels and other proteins involved
inionhomeostasishavebeenextensivelystudied.Oxidativemem-
brane damage has been found to be of great pathological impor-
tance in ischemia–reperfusion of myocardial tissue injury. At the
molecular level, membrane functions may be modiﬁed by direct
attackof ROSonitsrelatedcomponents.ROSexposureinﬂuences
the physical properties of membranes, and hence ion transport
mainlyduetochangesinthedielectricconstant,whichisenhanced
by lipid peroxidation (Killig and Stark,2002). This effect is caused
by the accumulation of polar products of lipid peroxidation,
or secondary reactive species, in the membrane interior. Conse-
quently, membrane barrier, experienced by the charged species
throughout their translocation across the membrane, would be
further reduced (Stark,2005) giving rise to many of the activation
phenomenaofmembranetransportdescribedintheliterature.Ion
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channels(contrarytoioncarriers)providepolarpathwaysforions
across the hydrophobic membrane barrier. For their proper func-
tioning,thestructuralelementformingthepolarpathwaymustbe
inserted into the membrane,a process which is substantially facil-
itated by increased dielectric constant. Membrane proteins have a
natural lipid environment and are therefore particularly exposed
to an eventual attack of secondary reactive species.
The oxidative modiﬁcation of (Na+K)-ATPase has been stud-
ied considering the direct and the indirect inactivation pathways
(Shao et al., 1995). In agreement with this view it was reported
that erythrocyte (Na+K)-ATPase activity correlated negatively
with 8-isoprostane (in vivo index of lipid peroxidation) in hyper-
tensive and normotensive subjects (Rodrigo et al.,2007a). Several
authors have found altered mRNA and/or protein levels of ion
channels during AF (Van Wagoner et al., 1997; Van Gelder et al.,
1999; Brundel et al., 2001). In this setting, downregulation has
been described for the L-type calcium channel (Lai et al., 1999),
the sarcoplasmic reticulum calciumATPase (Brundel et al.,1999),
and several potassium channel subunits (Brundel et al., 1999; Lai
et al., 1999), whereas the expression of other proteins involved
incalciumhandlinglikethesodium/calciumexchanger,phospho-
lamban,calsequestrin,andtheryanodinereceptorwerenotaltered
(Lai et al., 1999;Van Gelder et al., 1999; Brundel et al., 2001). It is
of interest to mention that electrical remodeling is capable to alter
ion channels being the base of AF,such as L-type calcium channel
(Cav1.2), inward rectiﬁer potassium channel (Kir2.1), transient
outward potassium channel (Kv4.3), ultrarapid delayed recti-
ﬁerpotassiumchannel(Kv1.5),acetylcholine-activatedpotassium
channel (Kir3.1), ATP-sensitive potassium channel (Kir6.2), fast
sodium channel (Nav1.5). For example, it has been shown that in
AF patients with a reduced density of outward potassium current,
the expression of the potassium channel Kv1.5 subunit decreases
(Van Wagoner et al., 1997). This indicates that the current den-
sities are inﬂuenced by alterations in channel protein expression
level, an observation that was also described in a dog model of
chronic AF (Gaspo et al., 1997; Yue et al., 1997, 1999). ROS pro-
duction occurs in the heart sarcolemmal and t-tubule membranes
where NOX2 is located and sensitizes nearby ryanodine recep-
tors in the sarcoplasmic reticulum. This triggers a burst of Ca2+
sparks and, consequently, arrhythmogenic Ca2+ waves (Prosser
et al., 2011). These effects were prevented by the antioxidant N-
(2-mercaptopropionyl) glycine in isolated cardiomyocytes, after
pretreatment with digitoxin, known to increases the incidence
of arrhythmogenic spontaneous Ca2+ waves, decreases the sar-
coplasmic reticulum Ca2+ load, and increases both ROS and
ryanodine thiol oxidation (Ho et al.,2011). In addition,inhibitors
of NADPH oxidase, mitochondrial ATP-dependent channels, or
permeability transition pore, but not inhibitors of xanthine oxi-
dase, also were able to inhibit these effects. Furthermore, it was
demonstrated that H2O2 enhances the late, slowly inactivating
current through cardiac Na channels, thereby leading to action
potential prolongation and arrhythmias (Song et al., 2006), being
Ca2+/calmodulin-dependent protein kinase II (CaMKII)δ sug-
gested as an important factor for ROS-induced arrhythmias.
This is supported by the ﬁnding that the expression and activ-
ity of CaMKII are increased in arrhythmias (Wagner et al., 2006),
although ROS-induced sarcoplasmic reticulum Ca2+ release may
be a prerequisite for ROS-dependent CaMKII activation. It is
of interest to mention that it was identiﬁed a ROS-dependent,
Ca2+ independent CaMKII activation by oxidative modiﬁcation
of methionine 281/282, thereby showing that direct activation of
CaMKII by ROS engenders Ca2+ autonomous activity,a clear but
previously molecular mechanism by which CaMKII can integrate
Ca2+ and ROS signals (Erickson et al., 2008).
There is considerable evidence supporting that the function
of the L-type Ca2+-channel is inﬂuenced by the redox state
of the cell, leading to intracellular Ca2+ overload. Ischemia–
reperfusion causes an increased in the production of 20-
hydroxyeicosatetraenoicacid(20-HETE),apotentvasoconstrictor
that activates L-type Ca2+ channels. Inhibition of 20-HETE pro-
duction has been shown to reduce infarct size caused by ischemia.
In isolated crat cardiomyocytes, it was shown that this effect
includes 20-HETE stimulation of NADPH oxidase-derived super-
oxide production, which activates L-type Ca2+ channels via a
PKC-dependentmechanism(Zengetal.,2010).Theeffectexplain-
ing the action of ROS on the heart was provided by the ﬁrst
time relating the concomitant disruption of calcium and energy
metabolism. It was concluded that ROS-induced glycolytic inhi-
bition and Ca2+ overload (Corretti et al., 1991). More recently,
it was reported that a related mechanism for the development of
atrial dysrhythmias is Ca2+ alternans, a subcellular phenomenon
caused by modulation of sarcoplasmic reticulum Ca2+ release,
which is mediated, at least in part, by local inhibition of energy
metabolism(KockskämperandBlatter,2002).Furthermore,atrial
myocytes glycolysis regulates Ca2+ release from the sarcoplasmic
reticulum by direct modulation of ryanodine receptors activity by
intermediates and products of glycolysis and modulation of sar-
coplasmic reticulum Ca2+-ATPase activity through local changes
of glycolytically derived ATP (Kockskämper et al., 2005). In sup-
port of these postulated mechanisms, it has been demonstrated
that glycolytic inhibition interacts with the aged and ﬁbrotic atria
toamplifyintracellularCa2+handlingabnormalitiesthatfacilitate
AF development (Ono et al., 2007). Furthermore, in aged ﬁbrotic
unlike in adult rat hearts,glycolytic inhibition promotes ventricu-
lar ﬁbrillation by activation of ATP-sensitive K channels,CaMKII,
andNa+–Ca2+-exchanger(Moritaetal.,2011),butthesearrhyth-
mias were suppressed by the reducing agent N-acetylcysteine and
CaMKII inhibitor KN-93 (Morita et al.,2009).
Gap junction proteins
Gapjunctionsareinvolvedincell–cellcoupling;theyformelectri-
cal conduits between adjacent myocardial cells, permitting rapid
spatialpassageoftheexcitationcurrentessentialtoeachheartbeat.
Arrhythmogenic decreases in gap junction coupling are a charac-
teristic of stressed, failing, and aging myocardium, but the mech-
anisms of decreased coupling are poorly understood. Intercellular
gap junction channels are formed by homomeric or heteromeric
connexin subunits (Köhler and Hoyer,2007),thus supporting the
concept that local intercellular electrical communication between
the cardiomyocytes occurs through these structures (Félétou and
Vanhoutte, 2006). This provides an electrical continuity allowing
a uniform membrane potential among coupled cells. Neverthe-
less, connexins functions are beyond facilitating the exchange of
metabolites and electrical signals between cells and contributing
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to cardiomyocyte volume regulation (Burra and Jiang,2011). The
role of gap junction channels on cardiac impulse propagation is
complex. Atrial muscle preferentially expresses connexins 40 and
43.Microtubuleshaveawell-studiedroleinthetrafﬁckingof con-
nexin 43 to the plasma membrane. EB1 is a protein involved in
the targeted delivery of connexin 43 to adherens junctions (Shaw
et al., 2007). Oxidative stress perturbs connexon forward trafﬁck-
ing along microtubules to gap junctions (Smyth et al., 2010) and
EB1 levels are reduced at intercalated disks in end-stage human
ischemic cardiomyopathy and in adult mouse hearts exposed to
acute ischemia–reperfusion injury or acute oxidative stress alone.
Furthermore, mutational disruption of the EB1–tubulin interac-
tion mimicked the effects of oxidant stress, including a reduction
in surface Cx43 expression (Tomaselli, 2010). In contrast, dietary
selenium, an antioxidant compound, exerts a cardioprotective
effect that might be mediated by a reduced oxidative stress, a
lower connexin 43 dephosphorylation, and a decreased TNF-α
expression (Tanguy et al.,2011). Furthermore,in endothelial cells
challenged by hypoxia-reoxygenation it was recently found that
p47phox rather than NADPH oxidase-derived ROS affects the
modulationof intercellularcoupling,suggestingacontributionof
a cross-talk between connexin 40 and NADPH oxidase (Yu et al.,
2010).
The modulation by gap junction channels is prominent in car-
diactissuessuchassinoatrialnode-atrialmuscles,atrioventricular
node-Hisbundle,Hisbundle–bundlebranch,andPurkinjeﬁbers-
ventricular muscles (Desplantez et al., 2007). Under conditions
of oxidative stress connexin 43 distribution pattern is heteroge-
neous giving rise to aberrant electrical conduction, facilitating
self-perpetuation of re-entry pathways thereby causing the devel-
opment of AF (Tansey et al.,2006;Wilhelm et al.,2006). However,
further studies are still lacking to determine the precise molecu-
lar basis linking oxidative stress with these complex phenomena
occurring in postoperative AF.
IMPLICATIONS OF INFLAMMATION FOR POSTOPERATIVE
ATRIAL FIBRILLATION
CLINICAL AND EXPERIMENTAL EVIDENCE
Inﬂammation is another heavily studied pathophysiological
process implicated in the pathophysiology of postoperative AF
(Aviles et al., 2003; Korantzopoulos et al., 2003; Boos et al.,
2006).AsidefromincreasedROSandcalciumoverload,inﬂamma-
tory cell inﬁltration into the myocardium may promote oxidative
injury, directly affecting atrial myocyte contraction (Mihm et al.,
2001), and electrical conduction (Kumagai et al., 1997). Accord-
ingly, patients with persistent AF have increased white cell count
(Abdelhadi et al., 2004), as well as plasma levels of the biomarker
C-reactive protein (CRP),relative to patients with paroxysmalAF,
and both of these patient groups have levels greater than those
with noAF (Chung et al.,2001). Thus,cardiac surgery with extra-
corporeal circulation leads to elevation of CRP,interleukin-6,and
the complement system (Gaudino et al.,2003; Canbaz et al.,2008;
Echahidi et al., 2008). The temporal course of AF occurring after
cardiac surgery closely follows the activation of the complement
system and release of proinﬂammatory cytokines. It was demon-
strated that the levels of CRP on postoperative day 2 were more
elevated in patients that experienced postoperative AF than in
thosethatdidnot(Bruinsetal.,1997).Itwasreportedthatamore
pronounced increase in postoperative white cell count indepen-
dently predicts development of postoperative AF (Lamm et al.,
2006). During the ﬁrst hour of reperfusion, superoxide triggers
neutrophil inﬁltration,which increases cardiac damage by further
release of ROS, inﬂammatory mediators, and proteases (Yellon
and Hausenloy, 2007). Chemokines are known to induce leuko-
cytemigration,growth,andactivation.Speciﬁcally,thechemokine
interleukin-8appearstohaveafundamentalroleinregulatingneu-
trophil localization in ischemic myocardium. In mice,CXCL2,the
homolog of human interleukin-8, is up-regulated in reperfused
myocardium (Vandervelde et al., 2007). The chemokine response
in ischemic tissues may be induced by various factors, including
ROS, cytokines (e.g., TNF-α and complement), and NF-κBa c t i -
vation (Chandrasekar et al., 2001). Prospective epidemiological
studies have shown that serum levels of CRP is a strong pre-
dictor of cardiovascular ischemia–reperfusion injury events, such
as myocardial infarction, postoperative AF, and stroke (Kinoshita
et al., 2011). Several studies revealed an independent association
ofhighplasmaCRPlevelswithadverseprognosisinacutemyocar-
dial infarction patients. Interestingly, preconditioning was found
to inhibit post-ischemic CRP increases in a rat model of acute
myocardial infarction (Valtchanova-Matchouganska et al.,2004).
Recently, it has been discussed the possible role of microR-
NAs in AF initiation and maintenance, as they inﬂuence cardiac
excitability and other processes pertinent to AF (Wang et al.,
2011b). Enhanced expression of miR-200,a family of microRNAs
affecting tumorigenesis and chemosensitivity, can modulate the
oxidative stress response. It was reported that miR-200a also sen-
sitizes tumors to treatment, which could account for the limited
success of antioxidants in clinical trials (Mateescu et al.,2011).
As a consequence of inﬂammation, impairment on the elec-
trical properties of atrial tissue, such as inhomogeneity in atrial
conduction may result (Ishii et al.,2005; Tselentakis et al.,2006).
INTERRELATIONSHIP BETWEEN OXIDATIVE STRESS AND
INFLAMMATION
Indeed the role of inﬂammation response in the intra- and extra-
cellular mechanisms implicated in this disorder cannot be sepa-
ratedfromthatofoxidativestress.Thebiochemicalnexusbetween
these two processes represents an essential piece in the puzzle.
It is of interest to mention that the transcriptional factor NF-
κB was found to play a pivotal role in this connection (Pavlovic
et al., 2002). It has been found that this transcriptional factor
responds to changes of the cellular oxidative status (Chandra
et al., 2000). When NF-κB is activated, by phosphorylation of its
inhibitory cofactor, it bonds to a DNA response element (ARE)
and promotes the transcription of genes coding to inﬂammation
mediators such as CRP,interleukin-6,and ﬁbrinogen,among oth-
ers(Liakopoulosetal.,2007).NF-κBactivationhasbeenassociated
with cardiac dysfunction, ventricular hypertrophy, and maladap-
tive cardiac growth (Opie et al., 2006). Increased levels of several
inﬂammation markers were found in serum and atria biopsies of
AF and postoperative AF patients (Korantzopoulos et al., 2003;
Neuman et al., 2007; Yu et al., 2010). Therefore it is reasonable to
assume that oxidative stress and inﬂammation response act in a
synergic way in the underlying pathophysiological mechanisms of
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postoperativeAF,givingthefoundationforstudiesinvolvinganti-
inﬂammatory AF therapy (Halonen et al., 2007; Goldstein et al.,
2008).
CELL DEATH IN ISCHEMIA–REPERFUSION: NECROSIS,
APOPTOSIS, AND AUTOPHAGY
Necrosis is a catastrophic type of cell death that is uncontrol-
lable and does not involve any speciﬁc mechanisms. Necrosis
is classically characterized by early plasma membrane rupture
and swelling of cytoplasmic organelles, in particular mitochon-
dria. It only refers to an irreversible stage of cell death, even
though dying cells generally progress from a reversible to an irre-
versible stage. ROS is involved in necrotic cardiomyocyte death
through MPT pore opening. Apoptosis has been implicated in
the pathogenesis of several acute and chronic conditions affect-
ing the cardiovascular system in the last decade (Gale et al.,
2011). The loss of endothelial cells precedes and may predis-
pose cardiomyocytes to undergo apoptosis (Dallabrida et al.,
2005), indicating that salvaging endothelial cells is of paramount
importance. It is likely that myocyte apoptosis is initiated dur-
ing ischemia but dependent on reperfusion injury. Reperfusion
appears to accelerate apoptosis when compared with permanent
occlusion (Whelan et al., 2010). Active caspases cleave vital sub-
strates in the cell, such as actin, actinin, β-myosin heavy chain,
myosin light chain, tropomyosin, and cardiac troponins, leading
to cellular demise (Communal et al., 2002). The“intrinsic”path-
way utilizes mitochondria to induce cell death by opening the
mitochondrial permeability transition pore (MPTP) or ruptur-
ing the outer mitochondrial membrane,both of which trigger the
sudden and complete release of cytochrome c and other proteins
from the intermembrane mitochondrial space into other cellular
compartments. The “intrinsic” pathway is primarily activated in
cardiac myocytes by cellular stimuli, such as hypoxia, ischemia–
reperfusion, and oxidative stress, which perturb the MPTP and
increase the permeability of the outer and inner mitochondr-
ial membranes (Singh et al., 2011). Once released, cytochrome
c binds to the cytosolic protein apaf1 and facilitates formation
of the “apoptosome” complex, which results in caspase-9 acti-
vation that provokes caspase-3 activation (Adrain and Martin,
2001). Smac/DIABLO indirectly activates caspases by sequester-
ing caspase-inhibitory proteins, while the mitochondrial release
of endonuclease-G and apoptosis-inducing factor results in their
translocation into the nucleus where they directly or indirectly
facilitate DNA fragmentation (Cande et al., 2002). Experimental
studiesinmicedemonstratedthattheactivationof Fascaninduce
apoptosis in cardiac myocytes and that Fas is a critical mediator
of myocardial infarction due to ischemia–reperfusion in vivo (Lee
et al.,2003).
Autophagy – in contrast to necrosis and apoptosis, autophagy
is primarily a survival mechanism. Cellular oxidative stress and
ROS have been reported to serve as important autophagic stim-
uli during periods of ischemia–reperfusion (Hariharan et al.,
2011). Autophagic degradation and removal of damaged oxi-
dized proteins in response to low to moderate oxidative stress is
reportedly beneﬁcial for cells. Conversely, severe oxidative stress
and increasing amounts of ROS may activate signaling path-
ways that lead to autophagy-induced cell death. In addition,
ultrastructural atrial remodeling characterized by an impaired
cardiac autophagy was found in patients developing postopera-
tive AF after coronary artery bypass surgery (García et al., 2011).
Whetherautophagypromotescellsurvivalordeathdependsupon
theseverityanddegreeofstressinthecellularenvironment(Essick
and Sam, 2010). During the initial period of ischemia, enzyme
XO is formed, and substrates for XO (hypoxanthine and xan-
thine) accumulate. Upon reperfusion, the reintroduction of O2
leads to XO-mediated superoxide generation due to the presence
of xanthine and hypoxanthine (Ushio-Fukai, 2009). During this
period, ATP generation decreases and results in the phosphory-
lation of 5  adenosine monophosphate-activated protein kinase
(AMPK),which leads to autophagosome formation through inhi-
bition of mammalian target of rapamycin (mTOR; Matsui et al.,
2008). Meanwhile, ROS damage organelles and cytosolic proteins
and cause mitochondrial lipid peroxidation, all of which exacer-
bate autophagy (Juhaszova et al., 2004). Additionally, antioxidant
enzymes, such as CAT and SOD, are targeted by autophago-
somes. This ultimately leads to the induction of cell death and
is thus detrimental to tissue function. Furthermore,AMPK activ-
itydecreasesduringreperfusion,thusincreasingautophagicdeath
andup-regulatingbeclin-1(Zhuetal.,2007).Autophagyhasbeen
reportedtobeinvolvedincardioprotectionagainstlethalischemic
injury; thus, repetitive ischemia by coronary stenosis or occlu-
sion enhances autophagy and subsequent cardioprotection when
compared with classical ischemia–reperfusion insult (Yan et al.,
2009).Aside from the key role that the chemokine MCP-1 plays in
cardiac damage following ischemia, it also mediates autophagy
through MCP-1-induced protein (MCPIP), a novel zinc-ﬁnger
protein that has transcription factor-like activity (Zhou et al.,
2006). MCPI stimulates inducible NO synthase, translocation of
the NADPH oxidase subunit phox47 from the cytoplasm to the
membrane, ROS production, induction of endoplasmic reticu-
lumstressmarkersHSP40andautophagy,asindicatedbybeclin-1
induction,cleavageofmicrotubule-associatedprotein1lightchain
3 and autophagolysosome formation, and apoptosis, respectively
(Younce and Kolattukudy, 2010).
A wide survey of AF is beyond the scope of the present chapter.
Nevertheless, a mechanistic hypothesis representing the effects of
ischemia, as well as those derived from the re-establishment of
bloodﬂowintheischemicmyocardium,togetherwiththeinﬂam-
mation caused by the surgical procedure and enhanced by ROS is
presented in Figure 1.
PREVENTION OF POSTOPERATIVE ATRIAL FIBRILLATION
CURRENTLY AVAILABLE PHARMACOLOGIC PROPHYLAXIS
ThehighincidenceofpostoperativeAFhasledtothedevelopment
of therapies that target the sympathetic nervous system, refrac-
tory period, or alter cardiac conduction. In summary, available
evidence strongly supports the use of β-blockers as standard pro-
phylaxisof postoperativeAF(Koniarietal.,2010).However,while
these agents reduce the incidence of the arrhythmia, they do not
eliminateit.Moreover,β-blockersshouldnotbeusedinintolerant
patients or as additive therapy in high risk patients. To study the
evidence supporting the use of traditional pharmacologic thera-
pies,otherthanβ-blockers,forthepreventionof postoperativeAF,
the reader could be directed to a recent review (Davis et al.,2010).
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FIGURE1|S c hema representing the hypothesis for the role of oxidative
stress and inﬂammation in the pathophysiology of postoperative atrial
ﬁbrillation in patients subjected to cardiac surgery with extracorporeal
circulation. NF-κB, nuclear factor kappaB;TNF-α, tumor necrosis factor-α; IL -6,
interleukin-6;TGF-β, transforming growth factor-β; RP , refractory period.
Adapted from Rodrigo et al. (2008) with permission.
NOVEL THERAPEUTIC AGENTS
Atpresent,preventivestrategiesagainstpostoperativeAFofferonly
suboptimalbeneﬁts.Despiteimprovementsinanesthesia,surgical
technique,andmedicaltherapy,theincidenceof thiscomplication
of surgeryremainshigh.Likely,thiscouldbetheresultof alimited
knowledge of the mechanisms for the development of postopera-
tiveAF. Therefore,there is a need of alternative therapies.Accord-
ingly, newly identiﬁed pathways have given rise to novel strate-
giesunderinvestigation,includingrenin–angiotensin–aldosterone
modulators, statins, non-steroidal anti-inﬂammatory drugs, cor-
ticosteroids, thiazolidinediones, n−3 polyunsaturated fatty acids
(n−3 PUFA), ascorbic acid, N-acetylcysteine, and sodium nitro-
prusside. Our interest will be focused in the reinforcement of the
antioxidant defense system, since ROS could contribute to the
mechanism accounting for structural remodeling and inﬂamma-
tion of myocardial tissue through the occurrence of ischemia–
reperfusion events. Therefore, it should be expected a decreased
risk of myocardial tissue for the development postoperative AF in
the presence of increased antioxidant activity.
Antioxidants
The available evidence for oxidative stress in the pathophysiol-
ogy of postoperative AF has stimulated the prophylactic use of
antioxidants. Based on the pathogenic role of ROS and RNS, it
should be expected that treatments with exogenous antioxidant
agents protect against reperfusion injury. Clinical trials designed
tostudycardioprotectionbylong-termadministrationofvitamins
CandEhavefailedtodemonstratebeneﬁcialeffects(Flahertyetal.,
1994; Stephens et al.,1996; Rapola et al.,1997; GISSI-Prevenzione
Trial, 1999; Heart Protection Study Collaborative Group, 2000;
Yusuf et al., 2000; de Gaetano, 2001; Guan et al., 2003; Tsujita
etal.,2006;Cooketal.,2007;Sessoetal.,2008).Thisdisappointed
result could be due to the lack of consideration of the pharmaco-
dynamics and/or the biochemical properties of these compounds.
Thus,theefﬁcacyofvitaminCasROSscavengercannotbereached
by oral doses. In turn,high doses of vitamin E (more than 400IU)
could exert a prooxidant effect and should be avoided. Some
studies have suggested that antioxidant agents attenuate left ven-
tricular remodeling following acute myocardial infarction. When
these patients had undergone primary percutaneous translumi-
nal coronary angioplasty, pretreatment with allopurinol, an XO
inhibitor, resulted in effective inhibition of oxygen-derived rad-
ical generation during reperfusion therapy and left ventricular
function recovery (Guan et al., 2003). Accordingly, in a model
of AF induced by rapid atrial pacing in pigs, it was demonstrated
that increased activity of NADPH and xanthine oxidases in atrial
Frontiers in Physiology | Cardiac Electrophysiology April 2012 | Volume 3 | Article 93 | 8Rodrigo Prevention of postoperative atrial ﬁbrillation
tissue could account for increased superoxide anion, what was
prevented by the inhibitors apocinin and oxypurinol, respectively
(Dudley et al.,2005). More recently,administering the free radical
scavenger edaravone to patients with acute myocardial infarction
immediately prior to reperfusion signiﬁcantly reduced infarct size
and reperfusion arrhythmia (Tsujita et al., 2006). A prospective,
randomized, placebo-controlled pilot study reported a signiﬁ-
cant reduction of the incidence of postoperative AF in patients
undergoingcoronaryarterybypassand/orvalvesurgerywhowere
treated with N-acetylcysteine (Ozaydin et al., 2011). However,
other attempts, such as intravenous bolus of SOD (Yusuf et al.,
2000), showed no beneﬁcial effect on patient outcome.
Concerning the role of antioxidant vitamins in the prevention
of postoperative AF, although the scientiﬁc rationale, epidemio-
logicdata,andretrospectivestudieshavebeenpersuasive,prospec-
tive, randomized, placebo-controlled trials have not veriﬁed the
actualbeneﬁtof antioxidantvitaminsinhumandiseases(Rodrigo
et al., 2007b). There are several possible contributory factors that
could explain this discrepancy, and the lack of consideration of
basic aspects, such as the pharmacokinetic properties and bio-
chemicaleffectsofantioxidantvitaminsatthecelllevel.Consistent
with this view, previous attempts to reduce free radical produc-
tion with oral vitamin C following primary coronary angioplasty
for AMI failed to attenuate increased F2-isoprostane production
(Guan et al., 1999). Jaxa-Chamiec et al. (2005) performed a ran-
domized, double-blind, placebo-controlled multicentre study in
800 patients and analyzed the combined effects of vitamins C and
E through infusion and capsules but could not demonstrate a
majoreffectof thisantioxidanttreatmentontheclinicaloutcome,
although diabetic patients showed a reduction in 30-day cardiac
mortality (Jaxa-Chamiec et al., 2009). It should be noted that the
authors acknowledged that the dose of vitamin C used only raised
plasmalevelsto0.1mmol/L,aconcentration100timeslowerthan
that required for scavenging superoxide anion. Recently, a meta-
analysis of randomized controlled trials concluded that antiox-
idant vitamins C and E may have prophylactic effect to reduce
the incidence of postoperative AF and all-cause arrhythmia fol-
lowing cardiac surgery; however, the overall quality of current
studiesispoorandfurtherresearchisneeded(Harlingetal.,2011;
Rasoli et al., 2011). Most investigations on the protective effects
of vitamins C and E have merely focused on their antioxidant
power.However,thesecompoundshavethepotentialtoinﬂuencea
broadrangeof mechanismsunderlyinghumanhealthanddisease;
the biological properties of α-tocopherol and ascorbic acid over-
whelm their antioxidant effects. Despite the enormous interest in
antioxidant vitamins as potential protective agents against human
disease development, the actual contributions, and mechanisms
of suchcompoundsremainunclear.Thebiologicalpropertiesand
beneﬁcial effects of vitamins C and E against postoperative AF
have been reviewed (Rodrigo et al., 2010) and will be analyzed
separately.
Vitamin E
This antioxidant, primarily α-tocopherol, is the major peroxyl
radical scavenger in biological lipid phases, such as membranes
or LDL (Upston et al., 2001; Terentis et al., 2002). The antiox-
idant action of vitamin E has been ascribed to its ability to act
chemically as a lipid-based free radical chain-breaking molecule,
thereby inhibiting lipid peroxidation through its own conversion
into an oxidized product, α-tocopheroxyl radical. α-Tocopherol
can be restored by reducing α-tocopheroxyl radicals with redox-
active reagents, such as vitamin C or ubiquinol (Shi et al., 1999).
The discovery of α-tocopheryl phosphate, a novel and natural
water-soluble form of vitamin E, should expand the knowledge
of the roles of this vitamin in biological systems (Gianello et al.,
2005)andfacilitateitsintravenousadministration.Infact,vitamin
E oral supplementation hours before acute episodes of oxidative
stress may be not effective, but short-term parenteral administra-
tion was shown to enrich vitamin E in endothelial cells (Engelhart
et al., 1998). In clinical studies of ischemia–reperfusion injury,
positive effects of a multivitamin antioxidant solution, includ-
ing preoperative administration of vitamin E, were described for
revascularization of the lower extremities (Rabl et al., 1995), kid-
ney transplantation (Rabl et al., 1993), liver surgery, and aortic
aneurysmrepair(Bartelsetal.,2004).However,homologousstud-
ies in the myocardium have not been performed. Although it was
reported that long-term vitamin E supplements given at high
dosage (≥400IU/day) may increase all-cause mortality (Miller
et al., 2005), this was not the case for short-term administration
of conventional doses required for the prevention of myocardial
reperfusion damage.
Vitamin C
Intraarterialadministrationofhighdosesofascorbatehasdemon-
strated to abolish the in vivo effects of superoxide anion in the
impairment of vascular endothelial function in subjects with
essential hypertension (Schneider et al.,2005). In addition,recent
invitro studieshavealsobeensuccessfultostudytheeffectsinvitro
of oxidative stress with and without this vitamin C concentration,
thus validating ascorbate to counteract the effects of oxidative
stress (Virdis et al., 2009). It should be noted that most human
cells have vitamin C transporters, coupled with sodium transport
at a ratio Na:ascorbate=2:1, having a K0.5 by 70μmol/L, being
distributed about 90% in the cytosol (Mackenzie et al., 2008).
When vitamin C is given by mouth, the relationship between oral
dose and plasma concentration is sigmoidal. Its concentration in
plasma is tightly controlled and excess of vitamin C is excreted as
a function of dose, being completely saturated at doses of 400mg
dailyandhigher,producingasteady-stateplasmaconcentrationof
approximately80μmol/L(Graumlichetal.,1997).Unfortunately,
while this concentration approaches to that required for enzyme
modulation,itisnotenoughtoscavengesuperoxideanion.There-
fore,in settings accompanied by oxidative stress,such as the acute
myocardialinfarction,orpercutaneouscoronaryinterventionfol-
lowing acute myocardial infarction, it should not be expected a
beneﬁcial effect of oral administration of vitamin C in the pre-
vention of oxidative damage, and intravenous infusion could be
consideredwiththispurpose.Indeed,superoxidereactswithNOat
arate10 5-foldgreaterthantherateatwhichsuperoxidereactswith
ascorbic acid (Jackson et al., 1998). As a consequence, 10mmol/L
ascorbateisneededtosupportitscompetitionwithNOforsuper-
oxide. It should be expected a high rate of cellular transport at
10mmol/L ascorbate plasma concentration, being saturated the
transporters, as this concentration is much higher than V max.
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Short-term infusion of high vitamin C doses make possible to
reach peak concentrations higher than 20mmol/L,but being over
10mm/Lfor3h(Ducongeetal.,2008).Interestingly,plasmalevels
of such magnitude, or three times higher, have not demonstrated
adverse events, except in the case of known complications such
as renal failure or glucose 6 phosphate dehydrogenase deﬁciency
(Padayatty et al., 2010). Therefore, these data are consistent with
the fact that vitamin C high doses offer an unexplored therapeu-
tic opportunity to counteract the myocardial reperfusion damage
caused by percutaneous coronary intervention. Despite oral doses
of vitamin C fail to protect the heart against the effect of perox-
ynitrite,somebeneﬁcialeffectsotherthanthatof superoxidescav-
engingmaybeobservedwhenascorbateisadministeredfollowing
acute myocardial infarction. Accordingly, in patients undergoing
elective percutaneous coronary intervention, impaired microcir-
culatory reperfusion is improved by vitamin C infusion (Basili
et al., 2010). Furthermore, in patients subjected to thrombolysis,
SOD in the blood was found signiﬁcantly reduced; whereas the
activity of the oxidant enzyme XO, and malondialdehyde levels
were found signiﬁcantly increased. However, oral supplementa-
tion of vitamin C to the post reperfusion patients restored these
parameters back to normal or near normal levels (Bhakuni et al.,
2006). These effects could be related to the modulation of ROS
production by vitamin C. A major enzymatic source of ROS is
given by their production via NADPH oxidase, an enzyme sub-
jected to downregulation by vitamin C. In addition, vitamin C
prevents the oxidation of tetrahydrobiopterin,a cofactor of eNOS
that is highly sensitive to oxidation. When tetrahydrobiopterin
is oxidized, eNOS activity becomes uncoupled, resulting in the
production of superoxide rather than NO, thus enhancing the
consequences of oxidative damage (Yang and Ming,2006). There-
fore, it should be expected a beneﬁcial effect of vitamin C in the
outcome of patients, even at oral doses, when it is administered
before cardiac surgery with extracorporeal circulation. On this
line,another clinical model of oxidative stress likely to have bene-
ﬁcial effects of oral doses of vitamin C is postoperative AF. This is
supported by previous studies demonstrating a major reduction
in the incidence of postoperativeAF in patients subjected to coro-
nary artery bypass who were given 2g of vitamin C the day before
the surgery, followed by 500mg daily until the ﬁfth postopera-
tive day (Carnes et al., 2001). In agreement with these data, more
recentstudiesdemonstratedthatthecombinationof ascorbicacid
and β-blockers may be more effective in reducing postoperative
AF than β-blockers alone (Eslami et al., 2007), and that supple-
mentationof vitaminCreducestheincidenceof postoperativeAF,
thetimeneededforrhythmrestorationandlengthof hospitalstay
(Papoulidisetal.,2011).However,availabledataarefewandmore
large-scale clinical trials are still lacking to conﬁrm this beneﬁ-
cial effect of vitamin C (Rasoli et al., 2011). It is noteworthy that
vitamin C could also abrogate the beneﬁcial effects of ischemic
preconditioning, a phenomenon induced by a series of brief sub-
lethal episodes of ischemia and reperfusion prior to a potentially
lethal episode of ischemia that renders the heart more resistant to
myocardial infarction (Tsovolas et al., 2008). Likely, the precon-
ditioning is abolished due to an abrogation of ROS production, a
phenomenon that otherwise could give rise to a survival response
bytheantioxidantdefensesystem.Ascorbatepreloading,amongits
many effects,has been shown to down-regulate p47phox and thus
attenuate NADPH oxidase-derived ROS production (Wu et al.,
2007).
n−3 Polyunsaturated fatty acids
It has been demonstrated the electrophysiological effects of n−3
PUFAaccountfortheiracuteantiarrhythmicpotential,beingmore
remarkablewithDHAandEPAascomparedwithα-linolenicacid
(Milberg et al., 2011). However, while the anti-inﬂammatory or
antiarrhythmic effects of n−3 PUFA may decrease the risk of
postoperative AF, interventional studies have yielded conﬂicting
results. Thus,at present there exists a controversy respect the ben-
eﬁcialeffectsofn−3PUFAinthepreventionofAFrecurrenceafter
direct cardioversion (Kumar et al., 2011; Nodari et al., 2011; Oza-
ydin et al.,2011). Although the mechanism of postoperative AF is
based on acute factors, such as inﬂammation and oxidative stress,
the vulnerability of myocardial tissue will be dependent on the
tissue redox status at the time of receiving the oxidative challenge.
Likely,vitamins Cand Esupplementation contributes with a rein-
forcementof thenon-enzymaticantioxidantsystem.However,the
antioxidant enzymes also could be a target of interventions aimed
to induce up-regulation of their activities, thus further enhanc-
ing the antioxidant potential against the unavoidable ROS burst
during the tissue reperfusion. Low to moderate ROS production
is thought to lead to a survival response mediated by Nrf2. In
addition to repeated short-term ischemia–reperfusion cycles, or
through pharmacological agents, this response could be induced
by n−3 PUFA supplementation. Due to their highly unsaturated
chemical structure, n−3 PUFA are highly prone to peroxidation,
whichproceedsthroughbothenzymaticandnon-enzymaticpath-
ways.Therefore,thesecompoundssuitabletocreateaconditionof
increasedROSproductionregulatedbytheadministereddose.An
appropriate dose to cause increase of ROS concentration enough
to activate Nrf2 pathway, but not cell death pathways, will elicit a
survival response rendering the myocardial tissue more resistant
to a subsequent ROS exposure and derived consequences, such
as postoperative AF. In support of this view, experimental studies
performed in heart of rats supplemented with n−3 PUFA rich
ﬁsh oil demonstrated a signiﬁcant enhancement of the expres-
sion of antioxidant enzymes (Jahangiri et al., 2006). Some studies
aimed to the prevention of postoperative AF have demonstrated
a signiﬁcant reduction of its incidence in patients subjected to
cardiac surgery with extracorporeal circulation (Calò et al., 2005;
Mariscalco et al.,2010; Castillo et al.,2011). However,other stud-
ies found no evidence of a beneﬁcial effect of treatment with
n−3PUFAonthesepatients(Heidarsdottiretal.,2010;Saravanan
et al., 2010). It should be mentioned a meta-analysis that did not
demonstrate signiﬁcant effects of n−3 PUFA supplementation on
AF prevention (Liu et al., 2011), although these compounds may
favorably affect atrial remodeling in AF (Korantzopoulos et al.,
2005).Likely,thiscontroversyarisesfromthenatureof n−3PUFA
administered to patients, having a key role the 1/2=EPA/DHA
ratio. In fact, the three successful studies in diminishing the inci-
dence of the arrhythmia administered n−3 PUFA nearly in this
ratio. In turn,the unsuccessful studies showed a higher EPA/DHA
r a t i o .T h i sv i e wi ss u p p o r t e db yar e c e n ts t u d yr e p o r t i n gat r e n d
t o w a r dab e n e ﬁ tf r o mn−3 PUFA supplementation when the
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EPA/DHA ratio is 1/2 (Benedetto et al., 2011). However, more
mechanisticstudiestoascertainthemolecularbasisoftheseeffects
are still lacking.
HYPOTHESIS FOR A NOVEL THERAPEUTIC STRATEGY BASED
ON MODULATION OF THE ANTIOXIDANT SYSTEM
Cumulated evidence, previously discussed, leads to support the
view for a potential role of n−3 PUFA and vitamins C and E
in protecting the myocardial damage derived from reperfusion
following extracorporeal circulation. This hypothesis is based on
two-step regime applied from a week before surgery, composed
of (Zimmer et al., 2003) an oxidative stress stimulus to promote
up-regulation of the endogenous enzymatic antioxidant defense
system, through n−3 PUFA supplementation, followed by (Gille-
spieetal.,2005)areinforcementofthenon-enzymaticantioxidant
component through supplements of vitamins C and E (Rodrigo
et al.,2007b,2008). Under these conditions,it should be expected
a decreased vulnerability of cardiac tissue to the oxidative chal-
lengeoccurringbecauseof theischemia–reperfusioneventproper
of this surgery. Consequently,taking into account the role of ROS
and RNS in the development of postoperativeAF,this antioxidant
supplementation could reduce the incidence of the arrhythmia.
Although the available clinical trial are controversial to support
this hypothesis, the latter should be complemented with the need
to administer n−3 PUFA in a 1/2=EPA/DHA ratio, since all the
studies using this protocol found a successful prevention of post-
operativeAF.Inaddition,anindependenteffectof ascorbatecould
enhance this cardioprotection. This hypothesis is summarized in
Figure 2.
CONCLUDING REMARKS AND PERSPECTIVES
Postoperative AF is a common complication, particularly follow-
ing cardiac surgery with extracorporeal circulation. It increases
the incidence of other complications, hospital, and healthcare
costs. Although the precise pathophysiological mechanisms of
this arrhythmia related to cardiac surgery are poorly under-
stood, oxidative stress and inﬂammation in atrial tissue may
be causally related to AF. High ROS levels could give rise to
pathological effects of oxidative stress characterized by oxidative
damage, resulting in cell dysfunction, apoptosis, and/or necro-
sis. Conversely, at lower concentrations, local targeted produc-
tion of ROS serves as a second messenger system that transmits
biological information by highly speciﬁc modulation of intra-
cellular signaling molecules, enzymes, and proteins. The latter
process includes an adaptive response to enhance antioxidant
defenses, mainly by up-regulating antioxidant enzymes expres-
sion and/or anti-apoptotic pathways. The reduction of ROS, with
hydroxylradicalscavengers,intheheartattenuatestheratechanges
induced by hypoxia and reoxygenation, and also decreases the
burst ﬁring incidence. To date, prophylactic therapies for post-
operative AF are largely empirical and suboptimal. Despite the
uncertainty of the beneﬁcial effects provided by clinical studies,
optimal EPA/DHA ratio has been recently argued to explain the
preventive effects of n−3 PUFA against postoperative AF. The
FIGURE 2 | Mechanism supporting a novel strategy for the
protective effect of n−3 PUFA and antioxidant vitamin
administration against postoperative atrial ﬁbrillation in patients
subjected to cardiac surgery with extracorporeal circulation. EPA,
eicosapentaenoic acid; DHA, docosahexaenoic acid; PLC,
Phospholipase C;Tx A2,Thromboxane A2; IP3, Inositol trisphosphate;
Ca
++, cytosolic calcium. Adapted from Rodrigo et al. (2008) with
permission.
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hypothesis for a novel therapeutic strategy based on the para-
digmthatareinforcementoftheantioxidantsystembeforecardiac
surgery should decrease the vulnerability of myocardium to the
oxidative challenges is presented. Low to moderate ROS expo-
sure can be created by n−3 PUFA supplementation, giving rise
to up-regulation of antioxidant enzymes in cardiac tissue. Addi-
tionally, vitamins C and E are capable of the reinforcement of
non-enzymatic antioxidant defenses. The intervention supported
by this hypothesis would be safe, low cost, and readily avail-
able, and the systemic effects of this treatment make possible
its use in other clinical settings related to ischemia–reperfusion,
such as percutaneous coronary interventions following acute
myocardial infarction or transplantation of live organ donation.
The present study should encourage the design of clinical tri-
als aimed to offer new therapeutic opportunities to all these
patients.
ACKNOWLEDGMENTS
This study was supported by the Fondo Nacional de Desarrollo
Cientíﬁco y Tecnológico (FONDECYT),grant 1120594.
REFERENCES
Abdelhadi, R. H., Gurm, H. S., Van-
Wagoner, D. R., and Chung, M. K.
(2004). Relation of an exaggerated
rise in white blood cells after coro-
nary bypass or cardiac valve surgery
to development of atrial ﬁbrillation
postoperatively. Am. J. Cardiol. 93,
1176–1178.
Adam, O., Frost, G., Custodis, F., Suss-
man, M. A., Schäfers, H. J., Böhm,
M., and Laufs, U. (2007). Role of
Rac1 GTPase activation in atrial ﬁb-
rillation. J. Am. Coll. Cardiol. 50,
359–367.
Adrain,C.,and Martin,S. J. (2001). The
mitochondrial apoptosome: a killer
unleashed by the cytochrome seas.
Trends Biochem. Sci. 26, 390–397.
Akila, D’souza, B., Vishwanath, P.,
and D’souza, V. (2007). Oxidative
injury and antioxidants in coro-
naryarterybypassgraftsurgery:off-
pump CABG signiﬁcantly reduces
oxidative stress. Clin. Chim. Acta
375, 147–152.
Allessie, M., Ausma, J., and Schot-
ten,U. (2002). Electrical,contractile
and structural remodeling during
atrialﬁbrillation.Cardiovasc.Res.54,
230–246.
Alqahtani, A. A. (2010). Atrial ﬁbril-
lation post cardiac surgery trends
toward management. Heart Views
11, 57–63.
Ambrosio, G., and Tritto, I. (1999).
Reperfusion injury: experimental
evidence and clinical implications.
A m .H e a r tJ .138, S69–S75.
Attaran, S., Shaw, M., Bond, L., Pullan,
M. D., and Fabri, B. M. (2011). A
comparison of outcome in patients
with preoperative atrial ﬁbrillation
and patients in sinus rhythm. Ann.
Thorac. Surg. 92, 1391–1395.
Aviles, R. J., Martin, D. O., Apperson-
Hansen, C., Houghtaling, P. L.,
Rautaharju,P.,Kronmal,R.A.,Tracy,
R. P., Van Wagoner, D. R., Psaty, B.
M., Lauer, M. S., and Chung, M. K.
(2003). Inﬂammation as a risk fac-
tor for atrial ﬁbrillation. Circulation
108, 3006–3010.
Babu, G. G., Walker, J. M., Yellon, D.
M., and Hausenloy, D. J. (2011).
Peri-procedural myocardial injury
duringpercutaneouscoronaryinter-
vention: an important target for
cardioprotection. Eur. Heart J. 32,
23–31.
Bartels, M., Biesalski, H. K., Engelhart,
K., Sendlhofer, G., Rehak, P., and
Nagel, E. (2004). Pilot study on the
effect of parenteral vitamin E on
ischemia and reperfusion induced
liverinjury:adoubleblind,random-
ized, placebo-controlled trial. Clin.
Nutr. 23, 1360–1370.
Basili, S., Tanzilli, G., Mangieri, E.,
Raparelli, V., Di Santo, S., Pig-
natelli, P., and Violi, F. (2010).
Intravenous ascorbic acid infu-
sion improves myocardial perfusion
grade during elective percutaneous
coronary intervention: relationship
with oxidative stress markers. JACC
Cardiovasc. Interv. 3, 221–229.
Béard, T., Carrié, D., Boyer, M. J.,
Boudjemaa, B., Ferrières, J., Delay,
M., Bernadet, P., and Thouvenot,
J. P. (1994). Production of oxygen
free radicals in myocardial infarc-
tion treated by thrombolysis. Analy-
sis of glutathione peroxidase, super-
oxide dismutase and malondialde-
hyde. Arch. Mal. Coeur Vaiss. 87,
1289–1296.
Benedetto, U., Angeloni, E., Melina,
G., Danesi, T. H., Di Bartolomeo,
R., Lechiancole, A., Reﬁce, S.,
Roscitano, A., Comito, C., and
Sinatra, R. (2011). n-3 Polyun-
saturated fatty acids for the
prevention of postoperative atrial
ﬁbrillation: a meta-analysis of
randomized controlled trials. J.
Cardiovasc. Med. (Hagerstown). doi:
10.2459/JCM.0b013e32834a13c1.
[Epub ahead of print].
Bhakuni, P., Chandra, M., and Misra,
M. K. (2006). Effect of ascorbic acid
supplementation on certain oxida-
tive stress parameters in the post
reperfusion patients of myocardial
infarction. Mol. Cell. Biochem. 290,
153–158.
Boos, C. J., Anderson, R. A., and Lip,
G. Y. (2006). Is atrial ﬁbrillation an
inﬂammatorydisorder?Eur.HeartJ.
27, 136–149.
Bowie, A., and O’Neill, L. A. (2000).
Oxidative stress and nuclear factor-
kappaBactivation:areassessmentof
the evidence in the light of recent
discoveries. Biochem. Pharmacol. 59,
13–23.
Braunwald,E.,andKloner,R.A.(1985).
Myocardial reperfusion: a double-
edged sword? J. Clin. Invest. 76,
1713–1719.
Brown, D. I., and Griendling, K. K.
(2009). Nox proteins in signal trans-
duction. Free Radic. Biol. Med. 47,
1239–1253.
Bruins,P.,teVelthuis,H.,Yazdanbakhsh,
A. P., Jansen, P. G., van Hardevelt,
F. W., de Beaumont, E. M., Wilde-
vuur, C. R., Eijsman, L., Trouw-
borst, A., and Hack, C. E. (1997).
Activation of the complement sys-
tem during and after cardiopul-
monary bypass surgery: postsurgery
activation involves C-reactive pro-
tein and is associated with postop-
erative arrhythmia. Circulation 96,
3542–3548.
Brundel,B.J.,vanGelder,I.C.,Henning,
R. H., Tuinenburg, A. E., Deelman,
L. E., Tieleman, R. G., Grandjean, J.
G., van Gilst, W. H., and Crijns, H.
J. (1999). Gene expression of pro-
teins inﬂuencing the calcium home-
ostasis in patients with persistent
and paroxysmal atrial ﬁbrillation.
Cardiovasc. Res. 42, 443–454.
Brundel, B. J., Van Gelder, I. C., Hen-
ning,R. H.,Tuinenburg,A. E.,Wiet-
ses, M., Grandjean, J. G., Wilde, A.
A., Van Gilst, W. H., and Crijns, H.
J. (2001). Alterations in potassium
channel gene expression in atria of
patients with persistent and parox-
ysmal atrial ﬁbrillation: differential
regulationofproteinandmRNAlev-
els for K+ channels. J. Am. Coll.
Cardiol. 37, 926–932.
Burra,S.,andJiang,J.X.(2011).Regula-
tionof cellularfunctionbyconnexin
hemichannels. Int. J. Biochem. Mol.
Biol. 2, 119–128.
Calò, L., Bianconi, L., Colivicchi, F.,
Lamberti, F., Loricchio, M. L., de
Ruvo, E., Meo, A., Pandozi, C.,
Staibano,M.,andSantini,M.(2005).
N-3 Fatty acids for the prevention
of atrial ﬁbrillation after coronary
arterybypasssurgery:arandomized,
controlled trial. J. Am. Coll. Cardiol.
45, 1723–1728.
Canbaz, S., Erbas, H., Huseyin, S., and
Duran,E.(2008).Theroleofinﬂam-
mation in atrial ﬁbrillation follow-
ing open heart surgery. J. Int. Med.
Res. 36, 1070–1076.
Cande, C., Cohen, I., Daugas, E., Rav-
agnan, L., Larochette, N., Zamzami,
N., and Kroemer, G. (2002).
Apoptosis-inducing factor (AIF): a
novel caspase-independent death
effectorreleasedfrommitochondria.
Biochimie 84, 215–222.
Carnes,C.A.,Chung,M.K.,Nakayama,
T., Nakayama, H., Baliga, R. S.,
Piao, S., Kanderian, A., Pavia, S.,
Hamlin, R. L., McCarthy, P. M.,
Bauer, J. A., Van, and Wagoner,
D. R. (2001). Ascorbate attenuates
atrial pacing-induced peroxynitrite
formation and electrical remodeling
and decreases the incidence of post-
operativeatrialﬁbrillation.Circ.Res.
89, E32–E38.
Castillo, R., Rodrigo, R., Perez, F., Cere-
ceda, M., Asenjo, R., Zamorano, J.,
Navarrete, R., Villalabeitia, E., Sanz,
J., Baeza, C., and Aguayo, R. (2011).
Antioxidant therapy reduces oxida-
tive and inﬂammatory tissue dam-
age in patients subjected to cardiac
surgery with extracorporeal circula-
tion. Basic Clin. Pharmacol. Toxicol.
108, 256–262.
Ceconi,C.,Boraso,A.,Cargnoni,A.,and
Ferrari, R. (2003). Oxidative stress
in cardiovascular disease: myth or
fact? Arch. Biochem. Biophys. 420,
217–221.
Chandra, J., Samali, A., and Orre-
nius,S.(2000).Triggeringandmod-
ulation of apoptosis by oxidative
stress. Free Radic. Biol. Med. 29,
323–333.
Chandrasekar, B., Smith, J. B., and
Freeman, G. L. (2001). Ischemia-
reperfusion of rat myocardium
activates nuclear factor-kappaB
and induces neutrophil inﬁltration
via lipopolysaccharide-induced
CXC chemokine. Circulation 103,
2296–2302.
Frontiers in Physiology | Cardiac Electrophysiology April 2012 | Volume 3 | Article 93 | 12Rodrigo Prevention of postoperative atrial ﬁbrillation
Chen, Z., Siu, B., Ho, Y. S., Vincent,
R., Chua, C. C., Hamdy, R. C., and
Chua, B. H. (1998). Overexpression
of MnSOD protects against myocar-
dial ischemia/reperfusion injury in
transgenicmice.J.Mol.Cell.Cardiol.
30, 2281–2289.
Chung, M. K., Martin, D. O., Sprecher,
D.,Wazni,O.,Kanderian,A.,Carnes,
C. A., Bauer, J. A., Tchou, P. J.,
Niebauer, M. J., Natale, A., and
Van Wagoner, D. R. (2001). C-
reactiveproteinelevationinpatients
with atrial arrhythmias: inﬂamma-
tory mechanisms and persistence of
atrial ﬁbrillation. Circulation 104,
2886–2891.
Communal, C., Sumandea, M., de
Tombe, P., Narula, J., Solaro, R. J.,
and Hajjar, R. J. (2002). Functional
consequences of caspase activation
incardiacmyocytes.Proc.Natl.Acad.
Sci. U.S.A. 99, 6252–6256.
Cook, N. R., Albert, C. M., Gaziano,
J. M., Zaharris, E., MacFadyen, J.,
Danielson, E., Buring, J. E., and
Manson, J. E. (2007). A random-
ized factorial trial of vitamins C,
E, and beta-carotene in the sec-
ondarypreventionof cardiovascular
events in women: results from the
Women’s Antioxidant Cardiovascu-
larStudy(WACS).Arch.Intern.Med.
167, 1610–1618.
Cook-Mills,J. M.,Johnson,J. D.,Deem,
T. L., Ochi, A., Wang, L., and
Zheng,Y.(2004).Calciummobiliza-
tionandRac1activationarerequired
for VCAM-1 (vascular cell adhesion
molecule-1) stimulation of NADPH
oxidase activity. Biochem. J. 378,
539–547.
Corretti, M. C., Koretsune,Y., Kusuoka,
H., Chacko, V. P., Zweier, J. L., and
Marban, E. (1991). Glycolytic inhi-
bition and calcium overload as con-
sequences of exogenously generated
free radicals in rabbit hearts. J. Clin.
Invest. 88, 1014–1025.
Dallabrida, S. M., Ismail, N., Oberle,
J. R., Himes, B. E., and Rupnick,
M. A. (2005). Angiopoietin-1 pro-
motes cardiac and skeletal myocyte
survival through integrins. Circ. Res.
96, e8–e24.
Davis, E. M., Packard, K. A., and
Hilleman, D. E. (2010). Pharma-
cologic prophylaxis of postopera-
tive atrial ﬁbrillation in patients
undergoing cardiac surgery: beyond
beta-blockers. Pharmacotherapy 30,
274e–318e.
de Gaetano, G. (2001). Collaborative
Group of the Primary Prevention
Project. Low-dose aspirin and vit-
amin E in people at cardiovascular
risk: a randomised trial in general
practice. Collaborative Group of the
Primary Prevention Project. Lancet
357, 89–95.
De Vecchi, E., Pala, M. G., Di Credico,
G., Agape, V., Paolini, G., Bonini, P.
A.,Grossi,A.,and Paroni,R. (1998).
Relation between left ventricular
function and oxidative stress in
patients undergoing bypass surgery.
Heart 79, 242–247.
Debreceni, B., and Debreceni, L.
(2011). Why do homocysteine-
lowering B vitamin and antioxidant
E vitamin supplementations
appear to be ineffective in
the prevention of cardiovas-
cular diseases? Cardiovasc. Ther.
doi:10.1111/j.1755-5922.2011.00266.x
Desplantez,T.,Dupont,E.,Severs,N. J.,
and Weingart, R. (2007). Gap junc-
tion channels and cardiac impulse
propagation. J. Membr. Biol. 218,
13–28.
Duconge, J., Miranda-Massari, J. R.,
Gonzalez, M. J., Jackson, J. A.,
Warnock, W., and Riordan, N. H.
(2008). Pharmacokinetics of vit-
amin C: insights into the oral
and intravenous administration of
ascorbate. P. R. Health Sci. J. 27,
7–19.
Dudley, S. C. Jr., Hoch, N. E., McCann,
L.A.,Honeycutt,C.,Diamandopou-
los, L., Fukai, T., Harrison, D. G.,
Dikalov, S. I., and Langberg, J.
(2005). Atrial ﬁbrillation increases
production of superoxide by the left
atriumandleftatrialappendage:role
of the NADPH and xanthine oxi-
dases. Circulation 112, 1266–1273.
Echahidi,N.,Pibarot,P.,O’Hara,G.,and
Mathieu, P. (2008). Mechanisms,
prevention, and treatment of atrial
ﬁbrillation after cardiac surgery. J.
Am. Coll. Cardiol. 51, 793–801.
Elahi, M., Hadjinikolaou, L., and Gali-
nanes, M. (2003). Incidence and
clinical consequences of atrial ﬁbril-
lation within 1 year of ﬁrst-time iso-
lated coronary bypass surgery. Cir-
culation 108(Suppl. 1), II207–II212.
Elahi, M. M., Flatman, S., and Matata,
B. M. (2008). Tracing the ori-
gins of postoperative atrial ﬁbrilla-
tion: the concept of oxidative stress-
mediated myocardial injury phe-
nomenon. Eur. J. Cardiovasc. Prev.
Rehabil. 15, 735–741.
El-Chami, M. F., Kilgo, P., Thourani,V.,
Lattouf,O. M.,Delurgio,D. B.,Guy-
ton, R. A., Leon, A. R., and Puskas,
J. D. (2010). New-onset atrial ﬁbril-
lation predicts long-term mortality
after coronary artery bypass graft. J.
Am. Coll. Cardiol. 55, 1370–1376.
Engelhart, K., Jentzsch, A. M., Fürst,
P., and Biesalski, H. K. (1998).
Short-term parenteral application
of α-tocopherol leads to increased
concentration in plasma and tis-
sue of the rat. Free Radic. Res. 29,
421–426.
Erickson, J. R., Joiner, M. L., Guan, X.,
Kutschke, W., Yang, J., Oddis, C. V.,
Bartlett,R.K.,Lowe,J.S.,O’Donnell,
S. E.,Aykin-Burns,N.,Zimmerman,
M. C., Zimmerman, K., Ham, A. J.,
Weiss, R. M., Spitz, D. R., Shea, M.
A., Colbran, R. J., Mohler, P. J., and
Anderson, M. E. (2008). A dynamic
pathway for calcium-independent
activationof CaMKIIbymethionine
oxidation. Cell 133, 462–474.
Eslami, M., Badkoubeh, R. S., Mousavi,
M., Radmehr, H., Salehi, M.,
Tavakoli, N., and Avadi, M. R.
(2007). Oral ascorbic acid in com-
bination with beta-blockers is more
effective than beta-blockers alone in
the prevention of atrial ﬁbrillation
after coronary artery bypass graft-
ing. Tex. Heart Inst. J. 34, 268–274.
Essick,E. E.,and Sam,F. (2010). Oxida-
tive stress and autophagy in car-
diac disease, neurological disorders,
aging and cancer. Oxid. Med. Cell.
Longev. 3, 168–177.
Everett,T.H.4th,andOlgin,J.E.(2007).
Atrial ﬁbrosis and the mechanisms
of atrial ﬁbrillation. Heart Rhythm.
4(Suppl. 3), S24–S27.
Félétou, M., and Vanhoutte, P. M.
(2006). Endothelium-derived
hyperpolarizing factor: where are
we now? Arterioscler. Thromb. Vasc.
Biol. 26, 1215–1225.
Flaherty, J. T., Pitt, B., Gruber, J. W.,
Heuser,R.R.,Rothbaum,D.A.,Bur-
well, L. R., George, B. S., Kereiakes,
D. J., Deitchman, D., and Gustafson,
N. (1994). Recombinant human
superoxide dismutase (h-SOD) fails
to improve recovery of ventricu-
lar function in patients undergo-
ing coronary angioplasty for acute
myocardial infarction. Circulation
89, 1982–1991.
Fruehauf, J. P., and Meyskens, F. L.
(2007). Reactive oxygen species: a
breath of life or death? Clin. Cancer
Res. 13, 789–794.
Frustaci, A., Chimenti, C., Bellocci, F.,
Morgante, E., Russo, M. A., and
Maseri, A. (1997). Histological sub-
strate of atrial biopsies in patients
with lone atrial ﬁbrillation. Circula-
tion 96, 1180–1184.
Gale, C. P., Metcalfe, E., West, R. M.,
Das, R., Kilcullen, N., Morrell, C.,
Crook,R.,Batin,P.D.,Hall,A.S.,and
Barth, J. H. (2011). An assessment
of the concentration-related prog-
nostic value of cardiac troponin I
following acute coronary syndrome.
Am. J. Cardiol. 108, 1259–1265.
García, A., Eiras, S., Parguiña, A. F.,
Alonso,J.,Rosa,I.,Salgado-Somoza,
A.,Rico,T.Y.,Teijeira-Fernández,E.,
and González-Juanatey, J. R. (2011).
High-resolution two-dimensional
gel electrophoresis analysis of atrial
tissue proteome reveals down-
regulation of ﬁbulin-1 in atrial
ﬁbrillation. Int. J. Cardiol. 150,
283–290.
Gasparetto, C., Malinverno, A., Gulac-
ciati, D., Gritti, D., and Prosperini,
P. G. (2005). Specchia G, ricevuti G.
Antioxidant vitamins reduce oxida-
tive stress and ventricular remodel-
ing in patients with acute myocar-
dialinfarction.Int.J.Immunopathol.
Pharmacol. 18, 487–496.
Gaspo,R.,Bosch,R.F.,Bou-Abboud,E.,
and Nattel, S. (1997). Tachycardia-
induced changes in Na+ current
in a chronic dog model of atrial
ﬁbrillation.Circ.Res.81,1045–1052.
Gaudino, M., Andreotti, F., Zamparelli,
R., Di Castelnuovo, A., Nasso, G.,
Burzotta, F., Iacoviello, L., Donati,
M. B., Schiavello, R., Maseri, A.,
and Possati,G. (2003). The -174G/C
interleukin-6 polymorphism inﬂu-
ences postoperative interleukin-6
levels and postoperative atrial ﬁbril-
lation.Isatrialﬁbrillationaninﬂam-
matory complication? Circulation
108(Suppl. 1), II195–II199.
Gianello,R.,Libinaki,R.,Azzi,A.,Gavin,
P. D., Negis, Y., Zingg, J. M., Holt,
P., Keah, H. H., Griffey, A., Small-
ridge, A., West, S. M., and Ogru,
E. (2005). Alpha-tocopheryl phos-
phate: a novel, natural form of vit-
amin E. Free Radic. Biol. Med. 39,
970–976.
Gillespie, E. L., White, C. M., Kluger,
J., Rancourt, J. A., Gallagher, R.,
and Coleman, C. I. (2006). Cost-
effectiveness of amiodarone for
prophylaxis of atrial ﬁbrillation
after cardiothoracic surgery. Phar-
macotherapy 26, 499–504.
Gillespie, E. L., White, M., Kluger, J.,
Sahni, J., Gallagher, R., and Cole-
man, C. (2005). A hospital per-
spective on the cost-effectiveness
of beta-blockade for prophylaxis of
atrialﬁbrillationaftercardiothoracic
surgery. Clin. Ther. 27, 1963–1969.
GISSI-Prevenzione Trial. (1999).
Dietary supplementation with n-3
polyunsaturated fatty acids and vit-
amin E after myocardial infarction:
results of the GISSI-Prevenzione
Trial. Gruppo Italiano per lo Studio
della Sopravvivenza nell’Infarto
miocardico. Lancet 354, 447–455.
Goldstein, R. N., Ryu, K., Khrestian,
C., van Wagoner, D. R., and Waldo,
A. L. (2008). Prednisone prevents
inducible atrial ﬂutter in the canine
sterile pericarditis model. J. Cardio-
vasc. Electrophysiol. 19, 74–81.
www.frontiersin.org April 2012 | Volume 3 | Article 93 | 13Rodrigo Prevention of postoperative atrial ﬁbrillation
Grant, A. O. (2001). Molecular biology
of sodium channels and their role
in cardiac arrhythmias. A m .J .M e d .
110, 296–305.
Graumlich, J. F., Ludden, T. M., Conry-
Cantilena, C., Cantilena, L. R. Jr.,
Wang, Y., and Levine, M. (1997).
Pharmacokinetic model of ascorbic
acid in healthy male volunteers dur-
ing depletion and repletion. Pharm.
Res. 14, 1133–1139.
Guan, W., Osanai, T., Kamada, T.,
Hanada, H., Ishizaka, H., Onodera,
H., Iwasa, A., Fujita, N., Kudo,
S., Ohkubo, T., and Okumura, K.
(2003). Effect of allopurinol pre-
treatment on free radical generation
after primary coronary angioplasty
for acute myocardial infarction. J.
Cardiovasc. Pharmacol. 41,699–705.
Guan, W., Osanai, T., Kamada, T.,
Ishizaka, H., Hanada, H., and Oku-
mura, K. (1999). Time course of
free radical production after pri-
mary coronary angioplasty for acute
myocardial infarction and the effect
of vitamin C. Jpn. Circ. J. 63,
924–928.
Halonen, J., Halonen, P., Järvinen, O.,
Taskinen, P., Auvinen, T., Tarkka,
M., Hippeläinen, M., Juvonen, T.,
andHartikainen,J.(2007).Corticos-
teroids for the prevention of atrial
ﬁbrillation after cardiac surgery: a
randomized controlled trial. JAMA
297, 1562–1567.
Hariharan, N., Zhai, P., and Sadoshima,
J. (2011). Oxidative stress stim-
ulates autophagic ﬂux during
ischemia/reperfusion. Antioxid.
Redox Signal. 14, 2179–2190.
Harling, L., Rasoli, S., Vecht, J.
A., Ashraﬁan, H., Kourliouros, A.,
and Athanasiou, T. (2011). Do
antioxidant vitamins have an anti-
arrhythmic effect following cardiac
surgery? A meta-analysis of ran-
domised controlled trials. Heart 97,
1636–1642.
Heart Protection Study Collaborative
Group. (2000). MRC/BHF Heart
Protection Study of antioxidant vit-
amin supplementation in 20,536
high-risk individuals: a randomised
placebo-controlled trial. Lancet 360,
23–33.
Heidarsdottir, R., Arnar, D. O., Sku-
ladottir,G.V.,Torfason,B.,Edvards-
son, V., Gottskalksson, G., Palsson,
R., and Indridason, O. S. (2010).
Does treatment with n-3 polyun-
saturated fatty acids prevent atrial
ﬁbrillation after open heart surgery?
Europace 12, 356–363.
Hess, M. L., and Manson, N. H.
(1984). Molecular oxygen: friend
and foe. The role of the oxygen
free radical system in the calcium
paradox, the oxygen paradox and
ischemia/reperfusion injury. J. Mol.
Cell. Cardiol. 16, 969–985.
Ho, H. T., Stevens, S. C., Terentyeva,
R., Carnes, C. A., Terentyev, D., and
Györke, S. (2011). Arrhythmogenic
adverse effects of cardiac glycosides
are mediated by redox modiﬁcation
of ryanodine receptors. J. Physiol.
(Lond.) 589(Pt 19),4697–4708.
Ishii, Y., Schuessler, R. B., Gaynor, S.
L., Yamada, K., Fu, A. S., Boineau,
J. P., and Damiano, R. J. Jr. (2005).
Inﬂammation of atrium after car-
diac surgery is associated with inho-
mogeneity of atrial conduction and
atrial ﬁbrillation. Circulation 111,
2881–2888.
Jackson, T. S., Xu, A., Vita, J. A., and
Keaney, J. F. Jr. (1998). Ascorbate
prevents the interaction of superox-
ideandnitricoxideonlyatveryhigh
physiological concentrations. Circ.
Res. 83, 916–922.
Jahangiri, A., Leifert, W. R., Kind, K.
L., and McMurchie, E. J. (2006).
Dietary ﬁsh oil alters cardiomy-
ocyte Ca2+ dynamics and antioxi-
dantstatus.FreeRadic.Biol.Med.40,
1592–1602.
Jaxa-Chamiec, T., Bednarz, B., Droz-
dowska, D., Gessek, J., Gniot,
J., Janik, K., Kawka-Urbanek, T.,
Maciejewski,P.,Ogórek,M.,Szpajer,
M.,and MIVIT Trial Group. (2005).
Antioxidant effects of combined vit-
amins C and E in acute myocardial
infarction.Therandomized,double-
blind, placebo controlled, multicen-
ter pilot Myocardial Infarction and
VITamins (MIVIT) trial. Kardiol.
Pol. 62, 344–350.
Jaxa-Chamiec, T., Bednarz, B.,
Herbaczynska-Cedro, K., Maciejew-
ski,P.,Ceremuzynski,L.,andMIVIT
Trial Group. (2009). Effects of
vitamins C and E on the outcome
after acute myocardial infarc-
tion in diabetics: a retrospective,
hypothesis-generating analysis from
the MIVIT study. Cardiology 112,
219–223.
Jones, W. K., Brown, M., Ren, X., He,
S.,and McGuinness,M. (2003). NF-
kappaB as an integrator of diverse
signaling pathways: the heart of
myocardial signaling? Cardiovasc.
Toxicol. 3, 229–254.
Juhaszova, M., Zorov, D. B., Kim, S.
H., Pepe, S., Fu, Q., Fishbein, K.
W., Ziman, B. D., Wang, S., Ytre-
hus, K., Antos, C. L., Olson, E. N.,
and Sollott, S. J. (2004). Glycogen
synthasekinase-3betamediatescon-
vergence of protection signaling to
inhibit the mitochondrial perme-
abilitytransitionpore.J.Clin.Invest.
113, 1535–1549.
Juránek, I., and Bezek, S. (2005). Con-
troversy of free radical hypothesis:
reactive oxygen species – cause or
consequence of tissue injury? Gen.
Physiol. Biophys. 24, 263–278.
Kilgore,K.S.,andLucchesi,B.R.(1993).
Reperfusion injury after myocardial
infarction: the role of free radi-
cals and the inﬂammatory response.
Clin. Biochem. 26, 359–370.
Killig, F., and Stark, G. (2002). Pho-
todynamic activation of ion trans-
port through lipid membranes and
its correlation with an increased
dielectric constant of the mem-
brane. Biochim. Biophys. Acta 1564,
207–213.
Kim, Y. M., Guzik, T. J., Zhang, Y.
H., Zhang, M. H., Kattach, H.,
Ratnatunga, C., Pillai, R., Chan-
non, K. M., and Casadei, B.
(2005). A myocardial Nox2 contain-
ing NAD(P)H oxidase contributes
to oxidative stress in human atrial
ﬁbrillation. Circ. Res. 97, 629–636.
Kinoshita, T., Asai, T., Takashima, N.,
Hosoba, S., Suzuki, T., Kambara, A.,
andMatsubayashi,K.(2011).Preop-
erative C-reactive protein and atrial
ﬁbrillation after off-pump coronary
bypass surgery. Eur. J. Cardiothorac.
Surg. 40, 1298–1303.
Kloner, R. A., and Jennings, R. B.
(2001a). Consequences of brief
ischemia: stunning, precondition-
ing, and their clinical implications:
part 1. Circulation 104, 2981–2989.
Kloner, R. A., and Jennings, R. B.
(2001b). Consequences of brief
ischemia: stunning, precondition-
ing, and their clinical implications:
part 2. Circulation 104, 3158–3167.
Kobayashi, M., and Yamamoto, M.
(2005). Molecular mechanisms acti-
vating the Nrf2-Keap1 pathway
of antioxidant gene regulation.
Antioxid. Redox Signal. 7, 385–394.
Kockskämper, J., and Blatter, L. A.
(2002). Subcellular Ca2+ alternans
represents a novel mechanism for
the generation of arrhythmogenic
Ca2+ waves in cat atrial myocytes.
J. Physiol. (Lond.) 545(Pt 1),65–79.
Kockskämper, J., Zima, A. V., and Blat-
ter, L. A. (2005). Modulation of sar-
coplasmicreticulumCa2+ releaseby
glycolysis in cat atrial myocytes. J.
Physiol. (Lond.) 564(Pt 3),697–714.
Köhler, R., and Hoyer, J. (2007). The
endothelium-derived hyperpolariz-
ing factor:insights from genetic ani-
malmodels.KidneyInt.72,145–150.
Kojodjojo, P., Peters, N. S., Davies,
D. W., and Kanagaratnam, P.
(2007). Characterization of the
electroanatomical substrate in
human atrial ﬁbrillation: the rela-
tionship between changes in atrial
volume, refractoriness, wavefront
propagation velocities, and AF
burden. J. Cardiovasc. Electrophysiol.
18, 269–275.
Koniari, I., Apostolakis, E., Rogkakou,
C., Baikoussis, N. G., and Dougenis,
D. (2010). Pharmacologic prophy-
laxis for atrial ﬁbrillation following
cardiac surgery: a systematic review.
J. Cardiothorac. Surg. 5, 121.
Korantzopoulos, P., Kolettis, T., Siogas,
K.,andGoudevenos,J.(2003).Atrial
ﬁbrillation and electrical remodel-
ing: the potential role of inﬂamma-
tion and oxidative stress. Med. Sci.
Monit. 9, RA225–RA229.
Korantzopoulos, P., Kolettis, T. M.,
Galaris, D., and Goudevenos, J. A.
(2007).Theroleofoxidativestressin
the pathogenesis and perpetuation
of atrial ﬁbrillation. Int. J. Cardiol.
115, 135–143.
Korantzopoulos, P., Kolettis, T. M.,
and Goudevenos, J. A. (2005).
The anti-inﬂammatory and antiox-
idant effects of long-chain n-3 fatty
acids or oil-rich ﬁsh may favor-
ably affect atrial remodeling in
atrial ﬁbrillation. Med. Hypotheses
64, 1245–1246.
Kumagai, K., Khrestian, C., and Waldo,
A. L. (1997). Simultaneous multi-
sitemappingstudiesduringinduced
atrial ﬁbrillation in the sterile peri-
carditis model. Insights into the
mechanism of its maintenance. Cir-
culation 95, 511–521.
Kumar, S., Sutherland, F., Morton, J. B.,
Lee, G., Morgan, J., Wong, J., Eccle-
ston, D. E., Voukelatos, J., Garg, M.
L., and Sparks, P. B. (2011). Long-
term omega-3 polyunsaturated fatty
acid supplementation reduces the
recurrence of persistent atrial ﬁbril-
lation after electrical cardioversion.
Heart Rhythm. 9, 483–491.
Lai, L. P., Su, M. J., Lin, J. L., Lin, F.
Y., Tsai, C. H., Chen, Y. S., Huang,
S. K., Tseng, Y. Z., and Lien, W. P.
(1999). Down-regulation of L-type
calcium channel and sarcoplasmic
reticular Ca(2+)-ATPase mRNA in
human atrial ﬁbrillation without
signiﬁcant change in the mRNA
of ryanodine receptor, calsequestrin
andphospholamban:aninsightinto
the mechanism of atrial electrical
remodeling. J. Am. Coll. Cardiol. 33,
1231–1237.
Lamm, G., Auer, J., Weber, T., Berent,
R., Ng, C., and Eber, B. (2006).
Postoperative white blood cell count
predicts atrial ﬁbrillation after car-
diac surgery. J. Cardiothorac. Vasc.
Anesth. 20, 51–55.
Lee,P.,Sata,M.,Lefer,D.J.,Factor,S.M.,
Walsh, K., and Kitsis, R. N. (2003).
Fas pathway is a critical mediator of
Frontiers in Physiology | Cardiac Electrophysiology April 2012 | Volume 3 | Article 93 | 14Rodrigo Prevention of postoperative atrial ﬁbrillation
cardiac myocyte death and MI dur-
ing ischemia–reperfusion in vivo.
Am. J. Physiol. Heart Circ. Physiol.
284, H456–H463.
Lefer, A. M., and Lefer, D. J. (1996).
The role of nitric oxide and
cell adhesion molecules on the
microcirculation in ischaemia-
reperfusion. Cardiovasc. Res. 32,
743–751.
Li, J. M., and Shah, A. M. (2004).
Endothelial cell superoxide gen-
eration: regulation and relevance
for cardiovascular pathophysiology.
Am. J. Physiol. Regul. Integr. Comp.
Physiol. 287, R1014–R1030.
Li, S. Y., Yang, X., Ceylan-Isik, A.
F., Du, M., Sreejayan, N., and
Ren, J. (2006). Cardiac contrac-
tile dysfunction in Lep/Lep obesity
is accompanied by NADPH oxi-
dase activation, oxidative modiﬁca-
tion of sarco(endo)plasmic reticu-
lumCa2+-ATPaseandmyosinheavy
chain isozyme switch. Diabetologia
49, 1434–1446.
Liakopoulos, O. J., Schmitto, J. D.,
Kazmaier, S., Bräuer, A., Quin-
tel, M., Schoendube, F. A., and
Dörge,H.(2007).Cardiopulmonary
and systemic effects of methylpred-
nisolone in patients undergoing car-
diac surgery. Ann. Thorac. Surg. 84,
110–118.
Lin,Y. K.,Lai,M. S.,Chen,Y. C.,Cheng,
C. C., Huang, J. H., Chen, S. A.,
Chen, Y. J., and Lin, C. I. (2012).
Hypoxia and reoxygenation mod-
ulate the arrhythmogenic activity
of the pulmonary vein and atrium.
Clin. Sci. 122, 121–132.
Liu,T.,Korantzopoulos,P.,Shehata,M.,
Li,G.,Wang,X.,and Kaul,S. (2011).
Prevention of atrial ﬁbrillation with
omega-3 fatty acids: a meta-analysis
of randomised clinical trials. Heart
97, 1034–1040.
Mackenzie,B.,Illing,A.C.,andHediger,
M. A. (2008). Transport model of
the human Na+-coupled L-ascorbic
acid(vitaminC)transporterSVCT1.
Am. J. Physiol. Cell Physiol. 294,
C451–C459.
Maisel, W. H., Rawn, J. D., and Steven-
son, W. G. (2001). Atrial ﬁbrillation
after cardiac surgery. Ann. Intern.
Med. 135, 1061–1073.
Mariscalco, G., Sarzi Braga, S., Banach,
M., Borsani, P., Bruno, V. D.,
Napoleone, M., Vitale, C., Piffaretti,
G., Pedretti, R. F., and Sala, A.
(2010). Preoperative n-3 polyunsa-
tured fatty acids are associated with
a decrease in the incidence of early
atrial ﬁbrillation following cardiac
surgery. Angiology 61, 643–650.
Martindale, J. L., and Holbrook, N.
J. (2002). Cellular response to
oxidative stress: signaling for suicide
and survival. J. Cell. Physiol. 192,
1–15.
Matata, B. M., Sosnowski, A. W., and
Galiñanes, M. (2000). Off-pump
bypass graft operation signiﬁcantly
reduces oxidative stress and inﬂam-
mation. Ann. Thorac. Surg. 69,
785–791.
Mateescu, B., Batista, L., Cardon, M.,
Gruosso, T., de Feraudy,Y., Mariani,
O., Nicolas, A., Meyniel, J. P., Cottu,
P., Sastre-Garau, X., and Mechta-
Grigoriou, F. (2011). miR-141 and
miR-200a act on ovarian tumorige-
nesis by controlling oxidative stress
response. Nat. Med. 17, 1627–1235.
Mathew, J. P., Fontes, M. L., Tudor,
I. C., Ramsay, J., Duke, P., Mazer,
C. D., Barash, P. G., Hsu, P. H.,
Mangano, D. T., Investigators of the
Ischemia Research, and Education
Foundation, and Multicenter Study
of Perioperative Ischemia Research
Group. (2004). A multicenter risk
index for atrial ﬁbrillation after car-
diac surgery. J. Am. Med. Assoc. 291,
1720–1729.
Matsui, Y., Kyoi, S., Takagi, H., Hsu, C.
P., Hariharan, N., Ago, T., Vatner, S.
F., and Sadoshima, J. (2008). Mol-
ecular mechanisms and physiolog-
ical signiﬁcance of autophagy dur-
ing myocardial ischemia and reper-
fusion. Autophagy 4, 409–415.
Mihm, M. J., Yu, F., Carnes, C. A.,
Reiser, P. J., McCarthy, P. M., Van
Wagoner, D. R., and Bauer, J. A.
(2001). Impaired myoﬁbrillar ener-
getics and oxidative injury during
humanatrialﬁbrillation.Circulation
104, 174–180.
Milberg, P., Frommeyer, G., Kleideiter,
A., Fischer, A., Osada, N., Brei-
thardt, G., Fehr, M., and Eckardt,
L. (2011). Antiarrhythmic effects of
free polyunsaturated fatty acids in
anexperimentalmodelof LQT2and
LQT3 due to suppression of early
afterdepolarizations and reduction
of spatial and temporal dispersion
of repolarization. Heart Rhythm 8,
1492–1500.
Miller, E. R. III, Pastor-Barriuso, R.,
Dalal, D., Riemersma, R. A., Appel,
L. J., and Guallar, E. (2005). Meta-
analysis:high-dosagevitaminEsup-
plementation may increase all-cause
mortality. Ann. Intern. Med. 142,
37–46.
Moens, A. L., Claeys, M. J., Timmer-
mans, J. P., and Vrints, C. J. (2005).
Myocardial ischemia/reperfusion-
injury, a clinical view on a complex
pathophysiological process. Int. J.
Cardiol. 100, 179–190.
Morita, N., Lee, J. H., Bapat, A., Fish-
bein,M.C.,Mandel,W.J.,Chen,P.S.,
Weiss,J. N.,and Karagueuzian,H. S.
(2011). Glycolytic inhibition causes
spontaneous ventricular ﬁbrillation
in aged hearts. Am. J. Physiol. Heart
Circ. Physiol. 301, H180–H191.
Morita, N., Sovari, A. A., Xie, Y.,
Fishbein, M. C., Mandel, W. J.,
Garﬁnkel, A., Lin, S. F., Chen, P.
S., Xie, L. H., Chen, F., Qu, Z.,
Weiss, J. N., and Karagueuzian, H.
S. (2009). Increased susceptibility
of aged hearts to ventricular ﬁbril-
lation during oxidative stress. Am.
J. Physiol. Heart Circ. Physiol. 297,
H1594–H1605.
Murphy, M. P. (2009). How mitochon-
driaproducereactiveoxygenspecies.
Biochem. J. 417, 1–13.
Nattel, S., Maguy, A., Le Bouter, S., and
Yeh, Y. H. (2007). Arrhythmogenic
ion-channelremodelingintheheart:
heart failure, myocardial infarction,
and atrial ﬁbrillation. Physiol. Rev.
87, 425–456.
Negi, S., Sovari, A. A., and Dudley, S.
C. Jr. (2010). Atrial ﬁbrillation: the
emerging role of inﬂammation and
oxidative stress. Cardiovasc. Hema-
tol.Disord.DrugTargets 10,262–268.
Neuman, R. B., Bloom, H. L., and
Shukrullah, I. (2007). Oxidative
stress markers are associated with
persistent atrial ﬁbrillation. Clin.
Chem. 53, 1652–1657.
Niu, J., Wang, K., Graham, S., Azfer,
A., and Kolattukudy, P. E. (2011).
MCP-1-induced protein attenuates
endotoxin-induced myocardial dys-
function by suppressing cardiac NF-
κB activation via inhibition of IκB
kinase activation. J. Mol. Cell. Car-
diol. 51, 177–186.
Nodari, S., Triggiani, M., Campia, U.,
Manerba, A., Milesi, G., Cesana, B.
M., Gheorghiade, M., and Dei Cas,
L. (2011). n-3 Polyunsaturated fatty
acids in the prevention of atrial
ﬁbrillation recurrences after elec-
trical cardioversion: a prospective,
randomized study. Circulation 124,
1100–1106.
Olson, T. M., Michels, V. V., Ballew, J.
D., Reyna, S. P., Karst, M. L., Her-
ron, K. J., Horton, S. C., Rodehef-
fer, R. J., and Anderson, J. L. (2005).
Sodium channel mutations and sus-
ceptibility to heart failure and atrial
ﬁbrillation. J. Am. Med. Assoc. 293,
447–454.
Ono, N., Hayashi, H., Kawase, A., Lin,
S. F., Li, H., Weiss, J. N., Chen, P.
S., and Karagueuzian, H. S. (2007).
Spontaneous atrial ﬁbrillation initi-
ated by triggered activity near the
pulmonary veins in aged rats sub-
jected to glycolytic inhibition. Am.
J. Physiol. Heart Circ. Physiol. 292,
H639–H648.
Opie, L. H. (1991). Role of calcium
and other ions in reperfusion injury.
Cardiovasc. Drugs Ther. 5(Suppl. 2),
237–247.
Opie,L.H.,Commerford,P.J.,Gersh,B.
J.,andPfeffer,M.A.(2006).Contro-
versies in ventricular remodelling.
Lancet 367, 356–367.
Ozaydin, M., Erdoˇ gan, D., Tayyar, S.,
Uysal, B. A., Dogan, A., Içli, A.,
Ozkan, E., Varol, E., Türker, Y., and
Arslan, A. (2011). N-3 polyunsat-
urated fatty acids administration
does not reduce the recurrence rates
of atrial ﬁbrillation and inﬂamma-
tion after electrical cardioversion:
a prospective randomized study.
AnadoluKardiyol.Derg.11,305–309.
Padayatty, S. J., Sun, A. Y., Chen, Q.,
Espey, M. G., Drisko, J., and Levine,
M. (2010). Vitamin C: intravenous
use by complementary and alter-
native medicine practitioners and
adverseeffects.PLoSONE 5,e11414.
doi:10.1371/journal.pone.0011414
Papoulidis, P., Ananiadou, O., Chalvat-
zoulis, E., Ampatzidou, F., Koutso-
giannidis, C., Karaiskos, T., Madesis,
A., and Drossos, G. (2011). The role
of ascorbic acid in the prevention
of atrial ﬁbrillation after elective on-
pump myocardial revascularization
surgery: a single-center experience –
a pilot study. Interact. Cardiovasc.
Thorac. Surg. 12, 121–124.
Park, J. L., and Lucchesi, B. R. (1999).
Mechanisms of myocardial reperfu-
sion injury. Ann. Thorac. Surg. 68,
1905–1912.
Pavlovi´ c, D.,¯ Dor ¯ devi´ c, V., and Koci´ c,
G. (2002). A “cross-talk” between
oxidative stress and redox cell sig-
nalling. Med. Biol. 2, 131–137.
Pendergrass, K. D., Varghese, S. T.,
Maiellaro-Rafferty, K., Brown, M.
E., Taylor, W. R., and Davis, M.
E. (2011). Temporal effects of cata-
lase overexpression on healing after
myocardial infarction. Circ. Heart
Fail. 4, 98–106.
Prosser, B. L., Ward, C. W., and Led-
erer, W. J. (2011). X-ROS signaling:
rapidmechano-chemotransduction
in heart. Science 333, 1440–1445.
Rabl, H., Khoschsorur, G., Colombo,
T., Petritsch, P., Rauchenwald, M.,
Költringer, P., Tatzber, F., and Ester-
bauer, H. (1993). A multivita-
min infusion prevents lipid perox-
idation and improves transplanta-
tion performance. Kidney Int. 43,
912–917.
Rabl, H., Koschsorur, G., and Petek, W.
(1995). Antioxidant vitamin treat-
ment: effect on lipid peroxidation
and limb swelling after revasculari-
sation operations. W o r l dJ .S u r g .19,
738–744.
www.frontiersin.org April 2012 | Volume 3 | Article 93 | 15Rodrigo Prevention of postoperative atrial ﬁbrillation
Rader, F., Van Wagoner, D. R., Ellinor,
P. T., Gillinov, A. M., Chung, M.
K., Costantini, O., and Blackstone,
E. H. (2011). Inﬂuence of race
on atrial ﬁbrillation after cardiac
surgery. Circ.Arrhythm. Electrophys-
iol. 4, 644–652.
Rapola, J. M., Virtamo, J., Ripatti, S.,
Huttunen, J. K., Albanes, D., Tay-
lor, P. R., and Heinonen, O. P.
(1997). Randomised trial of alpha-
tocopherol and beta-carotene sup-
plements on incidence of major
coronary events in men with pre-
vious myocardial infarction. Lancet
349, 1715–1720.
Rasoli, S., Kourliouros, A., Harling,
L., and Athanasiou, T. (2011).
Does prophylactic therapy with
antioxidant vitamins have an
effect on atrial ﬁbrillation fol-
lowing cardiac surgery? Interact.
Cardiovasc. Thorac. Surg. 13,
82–85.
Rodrigo,R. (2009). Oxidative Stress and
Antioxidants: Their Role in Human
Disease. New York: Nova Science
Publishers
Rodrigo,R.,Bächler,J. P.,Araya,J.,Prat,
H., and Passalacqua, W. (2007a).
Relationship between (Na+K)-
ATPase activity, lipid peroxidation
and fatty acid proﬁle in erythrocytes
of hypertensive and normotensive
subjects. Mol. Cell. Biochem. 303,
73–81.
Rodrigo, R., Guichard, C., and Charles,
R. (2007b). Clinical pharmacology
and therapeutic use of antioxidant
vitamins. Fundam. Clin. Pharmacol.
21, 111–127.
Rodrigo, R., Cereceda, M., Castillo, R.,
Asenjo, R., Zamorano, J., Araya, J.,
Castillo-Koch, R., Espinoza, J., and
Larraín, E. (2008). Prevention of
atrial ﬁbrillation following cardiac
surgery: basis for a novel therapeu-
tic strategy based on non-hypoxic
myocardial preconditioning. Phar-
macol. Ther. 118, 104–127.
Rodrigo, R.,Vinay, J., Castillo, R., Cere-
ceda, M., Asenjo, R., Zamorano, J.,
Araya,J.,Castillo-Koch,R.,Espinoza,
J., and Larraín, E. (2010). Use of
vitamins C and E as a prophylac-
tic therapy to prevent postoperative
atrial ﬁbrillation. Int. J. Cardiol. 138,
221–228.
Saravanan, P., Bridgewater, B., West,
A. L., O’Neill, S. C., Calder, P.
C., and Davidson, N. C. (2010).
Omega-3 fatty acid supplementa-
tiondoesnotreduceriskofatrialﬁb-
rillationaftercoronaryarterybypass
surgery: a randomized, double-
blind, placebo-controlled clinical
trial. Circ. Arrhythm. Electrophysiol.
3, 46–53.
Saxena, A., Dinh, D. T., Smith, J. A.,
Shardey, G. C., Reid, C. M., and
Newcomb, A. E. (2012). Usefulness
of postoperative atrial ﬁbrillation as
an independent predictor for worse
early and late outcomes after iso-
lated coronary artery bypass graft-
ing (MulticenterAustralian Study of
19,497 Patients).Am. J. Cardiol. 109,
219–225.
Schneider, M. P., Delles, C., Schmidt,
B. M., Oehmer, S., Schwarz, T.
K., Schmieder, R. E., and John,
S. (2005). Superoxide scavenging
effects of N-acetylcysteine and vit-
amin C in subjects with essential
hypertension. A m .J .H y p e r t e n s .18,
1111–1117.
Sesso, H. D., Buring, J. E., Christen,
W. G., Kurth, T., Belanger, C., Mac-
Fadyen, J., Bubes, V., Manson, J. E.,
Glynn, R. J., and Gaziano, J. M.
(2008).Vitamins E and C in the pre-
vention of cardiovascular disease in
men: the Physicians’Health Study II
randomized controlled trial. JAMA
300, 2123–2133.
Shao, Q., Matsubara, T., Bhatt, S. K.,
and Dhalla, N. S. (1995). Inhibi-
tion of cardiac sarcolemma Na(+)-
K+ ATPase by oxyradical generat-
ing systems. Mol. Cell. Biochem. 147,
139–144.
Shaw, R. M., Fay, A. J., Puthenveedu,
M. A., von Zastrow, M., Jan, Y.
N., and Jan, L. Y. (2007). Micro-
tubule plus-end-tracking proteins
target gap junctions directly from
the cell interior to adherens junc-
tions. Cell 128, 547–560.
Shi, H., Noguchi, N., and Niki,
E. (1999). Comparative study on
dynamics of antioxidative action
of alpha-tocopheryl hydroquinone,
ubiquinol, and alpha-tocopherol
against lipid peroxidation. Free
Radic. Biol. Med. 27, 334–336.
Shiroshita-Takeshita, A., Brundel, B. J.,
and Nattel, S. (2005). Atrial ﬁbril-
lation: basic mechanisms, remod-
eling and triggers. J. Interv. Card.
Electrophysiol. 13, 181–193.
Singh, T., Sharma, S. D., and Katiyar,
S. K. (2011). Grape proanthocyani-
dins induce apoptosis by loss of
mitochondrial membrane potential
of human non-small cell lung can-
cer cells in vitro and in vivo. PLoS
ONE 6, e27444. doi:10.1371/jour-
nal.pone.0027444
Smyth,J.W.,Hong,T.T.,Gao,D.,Vogan,
J.M.,Jensen,B.C.,Fong,T.S.,Simp-
son, P. C., Stainier, D. Y., Chi, N.
C., and Shaw, R. M. (2010). Limited
forward trafﬁcking of connexin 43
reduces cell-cell coupling in stressed
human and mouse myocardium. J.
Clin. Invest. 120, 266–279.
Song, Y., Shryock, J., Wagner, S.,
Maier, L., and Belardinelli, L.
(2006). Blocking late sodium cur-
rent reduces hydrogen peroxide-
induced arrhythmogenic activity
and contractile dysfunction. J. Phar-
macol. Exp. Ther. 318, 214–222.
Stark, G. (2005). Functional conse-
quences of oxidative membrane
damage. J. Membr. Biol. 205, 1–16.
Stephens, N. G., Parsons, A., Schoﬁeld,
P. M., Kelly, F., Cheeseman, K.,
and Mitchinson, M. J. (1996). Ran-
domised controlled trial of vita-
min E in patients with coronary
disease: Cambridge Heart Antioxi-
dant Study (CHAOS). Lancet 347,
781–786.
Tahara, E. B., Navarete, F. D., and
Kowaltowski, A. J. (2009). Tissue-
, substrate-, and site-speciﬁc char-
acteristics of mitochondrial reac-
tive oxygen species generation. Free
Radic. Biol. Med. 46, 1283–1297.
Tanguy, S., Rakotovao, A., Jouan, M.
G., Ghezzi, C., de Leiris, J., and
Boucher,F.(2011).Dietaryselenium
intake inﬂuences Cx43 dephospho-
rylation, TNF-α expression and car-
diac remodeling after reperfused
infarction. Mol. Nutr. Food Res. 55,
522–529.
Tansey, E. E., Kwaku, K. F., Hammer, P.
E.,Cowan,D.B.,Federman,M.,Lev-
itsky, S., and McCully, J. D. (2006).
Reduction and redistribution of gap
and adherens junction proteins after
ischemiaandreperfusion.Ann.Tho-
rac. Surg. 82, 1472–1479.
Terentis, A. C., Thomas, S. R., Burr,
J. A., Liebler, D. C., and Stocker,
R. (2002). Vitamin E oxidation in
human atherosclerotic lesions. Circ.
Res. 90, 333–339.
Tomaselli, G. F. (2010). Oxidant stress
derails the cardiac connexon con-
nection. J. Clin. Invest. 120, 87–89.
Tselentakis,E.V.,Woodford,E.,Chandy,
J., Gaudette, G. R., and Saltman, A.
E. (2006). Inﬂammation effects on
the electrical properties of atrial tis-
sueandinducibilityof postoperative
atrial ﬁbrillation. J. Surg. Res. 135,
68–75.
Tsovolas, K., Iliodromitis, E.
K., Andreadou, I., Zoga, A.,
Demopoulou, M., Iliodromitis, K.
E., Manolaki, T., Markantonis, S.
L., and Kremastinos, D. T. (2008).
Acute administration of vita-
min C abrogates protection from
ischemic preconditioning in rabbits.
Pharmacol. Res. 57, 283–289.
Tsujita, K., Shimomura, H., Kaikita,
K., Kawano, H., Hokamaki, J.,
Nagayoshi,Y.,Yamashita,T.,Fukuda,
M., Nakamura, Y., Sakamoto, T.,
Yoshimura, M., and Ogawa, H.
(2006). Long-term efﬁcacy of edar-
avoneinpatientswithacutemyocar-
dial infarction. Circ. J. 70, 832–837.
Upston,J.M.,Witting,P.K.,Brown,A.J.,
Stocker, R., and Keaney, J. F. (2001).
Effect of vitamin E on aortic lipid
oxidation and intimal proliferation
after arterial injury in cholesterol-
fedrabbits.FreeRadic.Biol.Med.31,
1245–1253.
Ushio-Fukai, M. (2009). Compart-
mentalization of redox signaling
through NADPH oxidase-derived
ROS. Antioxid. Redox Signal. 11,
1289–1299.
Valko, M., Leibfritz, D., Moncol, J.,
Cronin,M.T.,Mazur,M.,andTelser,
J. (2007). Free radicals and antioxi-
dants in normal physiological func-
tions and human disease. Int. J.
Biochem. Cell Biol. 39, 44–84.
Valtchanova-Matchouganska, A.,
Gondwe, M., and Nadar, A. (2004).
The role of C-reactive protein in
ischaemia/reperfusion injury and
preconditioning in a rat model of
myocardial infarction. Life Sci. 75,
901–910.
Van Gelder, I. C., Brundel, B. J., Hen-
ning,R.H.,Tuinenburg,A.E.,Tiele-
man,R. G.,Deelman,L.,Grandjean,
J. G., De Kam, P. J., Van Gilst, W.
H., and Crijns, H. J. (1999). Alter-
ations in gene expression of pro-
teins involved in the calcium han-
dling in patients with atrial ﬁbrilla-
tion.J.Cardiovasc.Electrophysiol.10,
552–560.
Van Wagoner, D. R. (2003). Molecular
basisof atrialﬁbrillation:adreamor
a reality? J. Cardiovasc. Electrophys-
iol. 14, 667–669.
Van Wagoner, D. R. (2007). Recent
insights into the pathophysiology
of atrial ﬁbrillation. Semin. Thorac.
Cardiovasc. Surg. 19, 9–15.
Van Wagoner, D. R. (2008). Oxidative
stressandinﬂammationinatrialﬁb-
rillation: role in pathogenesis and
potential as a therapeutic target. J.
Cardiovasc. Pharmacol. 52,306–313.
Van Wagoner, D. R., Pond, A. L.,
McCarthy, P. M., Trimmer, J. S.,
and Nerbonne, J. M. (1997). Out-
wardK+currentdensitiesandKv1.5
expression are reduced in chronic
human atrial ﬁbrillation. Circ. Res.
80, 772–781.
Vandervelde,S.,van Luyn,M. J.,Rozen-
baum,M. H.,Petersen,A. H.,Tio,R.
A.,andHarmsen,M.C.(2007).Stem
cell-related cardiac gene expres-
sion early after murine myocar-
dial infarction. Cardiovasc. Res. 73,
783–793.
Verhaar, M. C., Westerweel, P. E., van
Zonneveld, A. J., and Rabelink, T.
J. (2004). Free radical production
Frontiers in Physiology | Cardiac Electrophysiology April 2012 | Volume 3 | Article 93 | 16Rodrigo Prevention of postoperative atrial ﬁbrillation
by dysfunctional eNOS. Heart 90,
494–495.
Villareal, R. P., Hariharan, R., Liu, B.
C., Kar, B., Lee, V. V., Elayda, M.,
Lopez,J.A.,Rasekh,A.,Wilson,J.M.,
and Massumi,A. (2004). Postopera-
tive atrial ﬁbrillation and mortality
after coronary artery bypass surgery.
J. Am. Coll. Cardiol. 43, 742–748.
Virdis,A.,Colucci,R.,Fornai,M.,Polini,
A., Daghini, E., Duranti, E., Ghisu,
N., Versari, D., Dardano, A., Blan-
dizzi, C., Taddei, S., Del Tacca, M.,
and Monzani, F. (2009). Inducible
nitric oxide synthase is involved in
endothelial dysfunction of mesen-
tericsmallarteriesfromhypothyroid
rats. Endocrinology 150, 1033–1042.
Wagner, S., Dybkova, N., Rasenack,
E. C. L., Jacobshagen, C., Fabritz,
L., Kirchhof, P., Maier, S. K. G.,
Zhang, T., Hasenfuss, G., Brown,
J. H., Bers, D. M., and Maier,
L. S. (2006). Ca2+/calmodulin-
dependent protein kinase II regu-
lates cardiac Na+ channels. J. Clin.
Invest. 116, 3127–3138.
Wang,Y.Y.,Liu,S.,Lian,F.,Yang,W. G.,
and Xue, S. (2011a). Toll-like recep-
tor 7/8 agonist resiquimod induces
latepreconditioninginneonatalcar-
diac myocytes. Acta Pharmacol. Sin.
32, 565–572.
Wang, Z., Lu, Y., and Yang, B. (2011b).
MicroRNAs and atrial ﬁbrillation:
new fundamentals. Cardiovasc. Res.
89, 710–721.
Wassmann, S., Laufs, U., Bäumer, A.
T., Müller, K., Konkol, C., Sauer, H.,
Böhm, M., and Nickenig, G. (2001).
Inhibition of geranylgeranylation
reduces angiotensin II-mediated
free radical production in vascular
smooth muscle cells: involvement of
angiotensinAT1receptorexpression
and Rac1 GTPase. Mol. Pharmacol.
59, 646–654.
Weisfeldt, M. L., Zweier, J., Ambrosio,
G., Becker, L. C., and Flaherty, J. T.
(1988). Evidence that free radicals
result in reperfusion injury in heart
muscle. Basic Life Sci. 49, 911–919.
Whelan, R. S., Kaplinskiy, V., and Kit-
sis, R. N. (2010). Cell death in the
pathogenesisof heartdisease:mech-
anisms and signiﬁcance. Annu. Rev.
Physiol. 72, 19–44.
Wilhelm, M., Kirste, W., Kuly, S.,
Amann, K., Neuhuber, W., Weyand,
M., Daniel, W. G., and Garlichs, C.
(2006). Atrial distribution of con-
nexin 40 and 43 in patients with
intermittent,persistent,and postop-
erative atrial ﬁbrillation. Heart Lung
Circ. 15, 30–37.
Wu, F., Schuster, D. P., Tyml, K.,
and Wilson, J. X. (2007). Ascorbate
inhibits NADPH oxidase subunit
p47phox expression in microvascu-
lar endothelial cells. Free Radic. Biol.
Med. 42, 124–231.
Yan,L.,Sadoshima,J.,Vatner,D. E.,and
Vatner, S. F. (2009). Autophagy in
ischemicpreconditioningandhiber-
nating myocardium. Autophagy 5,
709–712.
Yang,Z.,and Ming,X. F. (2006). Recent
advancesinunderstandingendothe-
lial dysfunction in atherosclerosis.
Clin. Med. Res. 4, 53–65.
Yellon, D. M., and Hausenloy, D.
J. (2007). Myocardial reperfusion
injury. N .E n g l .J .M e d .357,
1121–1135.
Younce, C. W., and Kolattukudy, P.
E. (2010). MCP-1 causes cardiomy-
oblast death via autophagy result-
ing from ER stress caused by oxida-
tive stress generated by inducing a
novel zinc-ﬁnger protein, MCPIP.
Biochem. J. 426, 43–53.
Yu, G., Bolon, M., Laird, D. W.,
and Tyml, K. (2010). Hypoxia and
reoxygenation-inducedoxidantpro-
duction increase in microvascular
endothelial cells depends on con-
nexin40. Free Radic. Biol. Med. 49,
1008–1013.
Yue, L., Feng, J., Gaspo, R., Li, G. R.,
Wang, Z., and Nattel, S. (1997).
Ionic remodeling underlying action
potential changes in a canine model
of atrial ﬁbrillation. Circ. Res. 81,
512–525.
Yue, L., Melnyk, P., Gaspo, R., Wang,
Z., and Nattel, S. (1999). Molec-
ular mechanisms underlying ionic
remodeling in a dog model of
atrial ﬁbrillation. Circ. Res. 84,
776–784.
Yusuf,S.,Dagenais,G.,Pogue,J.,Bosch,
J., and Sleight, P. (2000). Vitamin
Esupplementationandcardiovascu-
lar events in high-risk patients. The
Heart Outcomes Prevention Evalua-
tion Study Investigators. N. Engl. J.
Med. 342, 154–160.
Zeng, Q., Han, Y., Bao, Y., Li, W.,
Li, X., Shen, X., Wang, X., Yao,
F., O’Rourke, S. T., and Sun, C.
(2010). 20-HETE increases NADPH
oxidase-derived ROS production
and stimulates the L-type Ca2+
channelviaaPKC-dependentmech-
anism in cardiomyocytes. Am. J.
Physiol. Heart Circ. Physiol. 299,
H1109–H1117.
Zhou, L., Azfer, A., Niu, J., Graham,
S., Choudhury, M., Adamski, F.
M., Younce, C., Binkley, P. F., and
Kolattukudy,P. E. (2006). Monocyte
chemoattractant protein-1 induces
a novel transcription factor that
causes cardiac myocyte apoptosis
and ventricular dysfunction. Circ.
Res. 98, 1177–1185.
Zhu, H., Jia, Z., Misra, B. R., Zhang, L.,
Cao, Z., Yamamoto, M., Trush, M.
A., Misra, H. P., and Li, Y. (2008).
Nuclear factor E2-related factor 2-
dependent myocardiac cytoprotec-
tion against oxidative and elec-
trophilic stress. Cardiovasc. Toxicol.
8, 71–85.
Zhu, H., Tannous, P., Johnstone, J. L.,
Kong,Y., Shelton, J. M., Richardson,
J. A., Le, V., Levine, B., Rothermel,
B. A., and Hill, J. A. (2007). Car-
diac autophagy is a maladaptive
response to hemodynamic stress. J.
Clin. Invest. 117, 1782–1793.
Zimmer, J., Pezzullo, J., Choucair, W.,
Southard, J., Kokkinos, P., Karasik,
P., Greenberg, M. D., and Singh, S.
N. (2003). Meta-analysis of antiar-
rhythmic therapy in the preven-
tion of postoperative atrial ﬁb-
rillation and the effect on hos-
pital length of stay, costs, cere-
brovascular accidents, and mor-
tality in patients undergoing car-
diac surgery. Am. J. Cardiol. 91,
1137–1140.
Zughaib, M. E., Tang, X. L., Sun, J.
Z., and Bolli, R. (1994). Myocar-
dialreperfusioninjury:factormyth?
(1994). A 1993 appraisal of a seem-
ingly endless controversy. Ann. N. Y.
Acad. Sci. 723, 218–228.
Conﬂict of Interest Statement: The
author declares that the research was
conducted in the absence of any com-
mercial or ﬁnancial relationships that
could be construed as a potential con-
ﬂict of interest.
Received: 28 January 2012; accepted: 26
March 2012; published online: 12 April
2012.
Citation: Rodrigo R (2012) Prevention
of postoperative atrial ﬁbrillation: novel
andsafestrategybasedonthemodulation
of the antioxidant system. Front. Physio.
3:93. doi: 10.3389/fphys.2012.00093
This article was submitted to Frontiers in
Cardiac Electrophysiology, a specialty of
Frontiers in Physiology.
Copyright © 2012 Rodrigo. This is an
open-access article distributed under the
terms of the Creative Commons Attribu-
tionNonCommercialLicense,whichper-
mits non-commercial use, distribution,
and reproduction in other forums, pro-
vided the original authors and source are
credited.
www.frontiersin.org April 2012 | Volume 3 | Article 93 | 17